Page last updated: 2024-08-23

epirubicin and Adenocarcinoma, Basal Cell

epirubicin has been researched along with Adenocarcinoma, Basal Cell in 347 studies

Research

Studies (347)

Timeframe	Studies, this research(%)	All Research%
pre-1990	21 (6.05)	18.7374
1990's	87 (25.07)	18.2507
2000's	115 (33.14)	29.6817
2010's	114 (32.85)	24.3611
2020's	10 (2.88)	2.80

Authors

Authors	Studies
Allum, WH; Bhogal, RH; Chau, I; Chaudry, A; Cunningham, D; Fribbens, C; Gerlinger, M; Kumar, S; Malietzis, G; Moussa, O; Rao, S; Starling, N; Watkins, D	1
Deva, S; Findlay, M; Hitchen, N; Lawrence, B; Waldron, NR	1
Bapat, B; Brown, J; Candrilli, SD; García-Foncillas, J; Kaye, JA; Liepa, AM; Lorenzen, S; Madhwani, S	1
Jain, A	1
Mini, E; Roviello, F; Roviello, G	1
Bateman, A; Byrne, JP; Grace, BL; Iveson, T; Jackson, A; Kelly, JJ; Noble, F; Pucher, PH; Rahman, SA; Rees, C; Underwood, TJ; Walker, RC	1
Begum, R; Braconi, C; Chau, I; Cresswell, GD; Crosby, T; Cunningham, D; Fassan, M; Fernandez-Mateos, J; Fontana, E; Hahne, JC; Harbery, A; Hedayat, S; Hulkki-Wilson, S; Kouvelakis, K; Lampis, A; Mansoor, W; Middleton, G; Okines, A; Peckitt, C; Rao, S; Salati, M; Seidlitz, T; Smyth, EC; Sottoriva, A; Stange, DE; Starling, N; Valeri, N; Vivanco, I; Vlachogiannis, G; Waddell, T; Wadsley, J; Watkins, D; Wotherspoon, A	1
Al-Batran, SE; Ganguli, A; Lordick, F; Morlock, R; Sahin, U; Türeci, Ö	1
Ajani, J; Allen, CJ; Badgwell, BD; Blum, M; Blumenthaler, AN; Das, P; Dineen, SP; Fleming, JB; Hoffe, SE; Ikoma, N; Mansfield, PF; Mehta, RJ; Minsky, BD; Pimiento, JM; Pointer, DT; Smith, GL	1
Gęca, K; Małecka-Massalska, T; Mlak, R; Pelc, Z; Polkowski, WP; Rawicz-Pruszyński, K; Sędłak, K; Skórzewska, M	1
Boussioutas, A; Crain, M; Darling, G; Findlay, M; Gebski, V; Haustermans, K; Kron, T; Leong, T; Lordick, F; Michael, M; Miller, D; Murray, WK; O'Connell, RL; Simes, J; Smithers, BM; Swallow, C; Verghis, J; Willis, D; Wong, R; Zalcberg, J	1
Anderegg, MCJ; Gisbertz, SS; Hulshof, MCCM; Los, M; Mohammed, NH; Ruurda, JP; van Berge Henegouwen, MI; van der Sluis, PC; van Hillegersberg, R; van Laarhoven, HWM; van Vulpen, M; Wiezer, MJ	1
Bruns, CJ; Schröder, W	1
Fitzgerald, RC; Griffiths, E; Lloyd, MA; Mercer, S; Noble, F; O'Donovan, M; O'Neill, JR; Parsons, SL; Turkington, R; Underwood, TJ	1
Alberts, SR; Berg, DJ; Bjarnason, GA; Ciombor, K; Dragovich, T; Enzinger, PC; Fuchs, CS; Goldberg, RM; Gunderson, LL; Haller, DG; Ilson, D; Mamon, HJ; Mayer, RJ; Meyerhardt, J; Niedzwiecki, D; O'Reilly, E; Swanson, RS; Tepper, JE; Venook, AP; Willett, CG; Ye, X	1
Dodo, M; Hirakawa, H; Kato, Y; Koseki, T; Kumagai, M	1
Hoehler, T; Kanzler, S; Kunzmann, V; Lordick, F; Maderer, A; Meyer, HJ; Mihaljevic, AL; Moehler, M; Mönig, S; Sandermann, A; Schroll, S; Schuhmacher, C; Stahl, M; Tannapfel, A; Thuss-Patience, P; Wilke, H	1
Felipe, AV; Forones, NM; França, JP; Moraes, AA; Oliveira, J; Silva, TD	1
Hepworth, R; Smith, E; Tin, AW; Wadd, N; Walker, J; Wilson, D	1
Aparicio, T; Azzedine, A; Barbier, E; Bouche, O; Chapelle, N; Cohen, R; Dahan, L; Etienne, PL; Gornet, JM; Guimbaud, R; Hammel, P; Le Malicot, K; Lepage, C; Louvet, C; Mineur, L; Nguyen, S; Phelip, JM; Samalin, E; Sefrioui, D; Touchefeu, Y	1
Belkhiri, A; Hong, J; Maacha, S	1
Ahmad, S; Biesiada, J; Chakrabarti, J; Chang, J; Hawkins, J; Helmrath, M; Holokai, L; Mahe, M; Medvedovic, M; Nowacki, LM; Shroyer, N; Steele, NG; Sundaram, N; Wang, J; Zavros, Y	1
Anthoney, A; Germetaki, T; Kamposioras, K; Kordatou, Z; Mansoor, W; Nasralla, M; Owen-Holt, V; Papaxoinis, G; Stamatopoulou, S; Weaver, JMJ	1
Bowrey, DJ; Chung, WY; Dennison, AR; Eltweri, AM; Morgan, B; Thomas, AL; Thompson, J	1
Ålgars, A; Kemppainen, J; Ristamäki, R; Salminen, P; Sundström, J; Vihervaara, H	1
Cho, H; Kang, YK	1
Bradley, CA	1
Allum, WH; Blazeby, JM; Cafferty, FH; Cunningham, D; Grabsch, HI; Griffin, SM; Langley, RE; Rowley, S; Smyth, EC	1
Evangelatov, A; Skrobanska, R; Yordanov, G	1
Asari, R; Ba-Ssalamah, A; Birner, P; Datler, P; Hejna, M; Pluschnig, U; Preusser, M; Schoppmann, SF; Schwameis, K; Zacherl, J	1
Bai, Y; Gao, J; Gong, YF; Jiang, B; Liu, F; Yuan, HH; Zhang, WJ; Zhang, WY	1
Liu, Y; Lo, YL; Tsai, JC	1
Barbachano, Y; Chau, I; Coxon, F; Crosby, T; Cunningham, D; Falk, S; Ferry, D; Frances, A; Gonzalez, D; Iveson, T; Mansoor, W; Middleton, G; Okines, AF; Okines, C; Peckitt, C; Saffery, C; Slater, S; Smith, D; Waddell, T; Wadsley, J; Waters, J; Wotherspoon, A	1
Bowrey, DJ; Cunnell, M; Khanna, A; Madhusudan, S; Parsons, SL; Reece-Smith, AM; Thomas, A	1
Eatock, MM; Gallagher, R; James, CR; Law, D; Millar, J; Morris, M; Napier, E; Purcell, C; Turkington, RC; Wilson, RH	1
Asari, R; Ba-Ssalamah, A; Birner, P; Hejna, M; Ilhan-Mutlu, A; Pluschnig, U; Preusser, M; Püspök, A; Schoppmann, SF; Schwameis, K; Zacherl, J	1
Guo, H; Liu, L; Liu, T; Liu, Y; Xu, Y; Yang, S; Yao, S; Yao, Z; Yuan, Y; Zhao, Y	1
Boukovinas, I; Christophyllakis, C; Georgoulias, V; Kakolyris, S; Malamos, N; Mavroudis, D; Papakotoulas, P; Politaki, E; Polyzos, A; Tryfonidis, K; Xenidis, N	1
Mirza, A; Pritchard, S; Welch, I	1
Bailey, IS; Byrne, JP; Curtis, NJ; Kelly, JJ; Noble, F; Underwood, TJ	1
Agterof, M; Borel-Rinkes, I; Lolkema, MP; Overkleeft, E; Reerink, O; Schipper, M; Siersema, P; Ubink, I; van der Sluis, P; van Hillegersberg, R; Vleggaar, F; Voest, E; Wijrdeman, H	1
Bailey, IS; Bateman, AC; Bateman, AR; Byrne, JP; Iveson, TJ; Kelly, JJ; Noble, F; Nolan, L; Rees, CN; Sharland, DM; Underwood, TJ	1
Goos, M; Illerhaus, G; Makowiec, F; Ruf, C; Ruf, G; Thomusch, O	1
Gao, X; Jing, T; Sun, Y; Wang, F; Xu, C; Zhang, C	1
Corrado, G; Cutillo, G; Maggioni, A; Mancini, E; Tomaselli, T; Vizza, E; Zanagnolo, V	1
Deng, W; Gong, JF; Li, J; Li, Y; Lu, M; Lu, ZH; Shen, L; Wang, QW; Zhang, XT; Zhou, J	1
Bilici, A	1
Christians, KK; Eastwood, D; Gamblin, TC; George, B; Johnston, FM; Miura, JT; Thomas, J; Tsai, S; Turaga, KK	1
Kalachand, R; King, S; Mongan, AM; Muldoon, C; O'Byrne, K; O'Farrell, NJ; Power, D; Ravi, N; Reynolds, JV	1
Anderson, A; Davidenko, I; Deptala, A; Donehower, RC; Dubey, S; Harrison, M; Iveson, T; Jiang, Y; Lakshmaiah, K; Loh, E; Nirni, S; Oliner, KS; Tang, R; Thomas, A; Tjulandin, S; Zhu, M	1
Adelstein, DJ; Bodmann, JW; Greskovich, JF; Ives, DI; Mason, DP; McNamara, MJ; Murthy, SC; Rice, TW; Rodriguez, CP; Rybicki, LA; Saxton, JP; Sohal, D; Stephans, K; Videtic, GM	1
André, T; Aparicio, T; Azzedine, A; Bedenne, L; Bouché, O; Boucher, E; Etienne, PL; Gornet, JM; Guimbaud, R; Hammel, P; Louvet, C; Maillard, E; Nguyen, S; Rebischung, C; Ries, P; Rougier, P; Ychou, M	1
Achiam, M; Bæksgaard, L; Duval, L; Holländer, C; Ladekarl, M; Larsen, AC; Pfeiffer, P; Schønnemann, K; Thorlacius-Ussing, O; Yilmaz, MK	1
Alcindor, T; Asselah, J; Cools-Lartigue, J; Eckert, E; Ferri, LE; Jones, D; Rousseau, M; Spicer, J; Vanhuyse, M; Zourikian, T	1
Brammer, K; Catton, JA; James, EJ; Parsons, SL; Randhawa, N; Tan, BH; Welch, NT	1
Boonstra, JJ; Borel Rinkes, IH; Lolkema, MP; Los, M; Ruurda, JP; Schipper, ME; Siersema, PD; Ubink, I; van der Horst, S; van der Sluis, PC; van Hillegersberg, R; Voest, EE; Wiezer, MJ	1
Bianco, V; Brozzetti, S; Fiaschi, AI; Francini, E; Laera, L; Marrelli, D; Petrioli, R; Rossi, G; Roviello, F; Roviello, G	1
Bichev, D; Breithaupt, K; Daum, S; Dogan, Y; Schmidt, SC; Thuss-Patience, PC; Treese, C; von Winterfeld, M	1
Berdel, WE; Brehler, AC; Hartmann, W; Kerkhoff, A; Kessler, T; Lenze, F; Palmes, D; Schliemann, C; Senninger, N; Ullerich, H; Wiebe, S	1
Blank, S; Bruckner, T; Büchler, MW; Grenacher, L; Heger, U; Jäger, D; Kunzmann, R; Langer, R; Lordick, F; Ott, K; Schmidt, T; Sisic, L; Springfeld, C; Stange, A; Weichert, W; Wiecha, C	1
Allum, WH; Chaudry, MA; Messager, M; Neofytou, K	1
Bronsert, P; Glatz, T; Hoeppner, J; Hopt, UT; Kulemann, B; Makowiec, F; Marjanovic, G; Schäfer, M; Sick, O; Zirlik, K	1
Budzynski, A; Fijorek, K; Konopka, K; Krzemieniecki, K; Lazar, A; Matlok, M; Ochenduszko, S; Pedziwiatr, M; Puskulluoglu, M; Sinczak-Kuta, A; Urbanczyk, K	1
Griffin, SM; Navidi, M; Sinclair, R; Sumpter, K	1
Caruso, R; D'Andrea, V; Diaz, E; Duran, H; Fabra, I; Ferri, V; Ferronetti, A; Ielpo, B; Malave, L; Plaza, C; Quijano, Y; Vicente, E	1
Cárdenas-Rebollo, JM; Colombo, N; Maggioni, A; Minig, L; Zanagnolo, V	1
Allum, WH; Braconi, C; Cunningham, D; Fassan, M; Ghidini, M; Grabsch, HI; Hahne, JC; Lampis, A; Langley, R; Nankivell, M; Okines, AF; Peckitt, C; Rugge, M; Smyth, EC; Valeri, N; Wotherspoon, A	1
Benson, AB; Burtness, BA; Cohen, SJ; Douglas, K; Enzinger, PC; Goldberg, RM; Ilson, DH; Mayer, RJ; Niedzwiecki, D; Venook, A; Villaflor, VM; Ye, X	1
Baretti, M; Bozzarelli, S; Fumagalli Romario, U; Giordano, L; Personeni, N; Rimassa, L; Roncalli, M; Rosati, R; Rubino, L; Santoro, A; Spaggiari, P; Tronconi, MC	1
Anzalone, AA; Cajozzo, M; Fatica, F; Geraci, G; Modica, G	1
Hou, J; Ji, Y; Liu, FL; Liu, TS; Shen, KT; Shen, ZB; Sun, YH; Wang, Y; Yu, S; Yu, YY; Zhao, NQ; Zhuang, RY	1
Anthoney, A; Cheeseman, S; Collinson, M; Dent, J; Hall, PS; Howard, H; Jones, M; Last, K; Lord, SR; Lowe, C; Marshall, H; Roy, R; Seymour, MT; Swinson, D; Velikova, G	1
Ajani, JA; Almhanna, K; Blum, MA; Catenacci, DV; Elimova, E; Hecht, JR; Janjigian, YY; Mulcahy, M	1
Bowman, CR; Dorrington, MS; Kaye, P; Madhusudan, S; Mumtaz, E; Pang, V; Parsons, SL; Reece-Smith, AM; Saunders, JH; Soomro, I	1
Goense, L; Haj Mohammad, N; Meijer, GJ; Mook, S; Ruurda, JP; van der Horst, S; van der Sluis, PC; van Hillegersberg, R; van Rossum, PSN; van Vulpen, M	1
Becerra, CR; Frenkel, EP; Tavana, D; Tran, HT; Verma, UN; Williams, NS	1
Bowman, A; Coleman, RE; Dunn, JA; Earl, HM; Fernando, IN; Hiller, L; Howard, HC; Poole, CJ; Ritchie, DM; Wardley, AM	1
Bonazzi, C; Chiari, S; Maneo, A; Mangioni, C	1
Gou, HY; Han, JS; Li, H; Li, SM; Qiao, J; Yang, R	1
Jensen, BY; Jensen, HA; Larsen, O; Pfeiffer, P; Schønnemann, KR; Yilmaz, M	1
Baselga, J; Benson, M; Cunningham, D; Hill, A; Kurek, R; Lüpfert, C; Oates, J; Rao, S; Starling, N; Wotherspoon, A	1
Arena, MG; Di Lauro, L; Fattoruso, SI; Giacinti, L; Giannarelli, D; Lopez, M; Sergi, D	1
Kolluri, RB; Raouf, S; Tipples, K	1
Chang, JW; Chen, CH; Lin, CM; Tsao, TC	1
Arcidiacono, PG; Balzano, G; Cereda, S; Di Carlo, V; Mazza, E; Nicoletti, R; Passoni, P; Reni, M; Rognone, A; Villa, E; Zerbi, A	1
Allum, W; Ashley, S; Benson, M; Brown, G; Chau, I; Cunningham, D; Oates, J; Okines, A; Riddell, A; Starling, N; Stavridi, F; Thomas, J; Thompson, J; Wotherspoon, A	1
Abe, R; Kimijima, I; Kimura, M; Koyama, H; Miura, S; Nomura, Y; Ohashi, Y; Takashima, S; Takatsuka, Y; Tashiro, H; Toi, M; Tominaga, T	1
Adamou, A; Athanasiadis, A; Boukovinas, I; Christophyllakis, C; Georgoulias, V; Kakolyris, S; Kalbakis, K; Karvounis, N; Kouroussis, C; Malamos, N; Mavroudis, D; Papakotoulas, P; Polyzos, A; Syrigos, K; Vamvakas, L; Varthalitis, I; Ziras, N	1
Chen, G; Fu, LW; Liang, YJ; Qiu, HB; Yuan, SQ; Zhang, LY; Zhou, ZW	1
Li, J; Li, Y; Lu, M; Shen, L; Zhang, XD	1
Fareed, KR; Ilyas, M; Kaye, PV; Lobo, DN; Madhusudan, S; Parsons, SL; Soomro, IN	1
Beal, K; Damast, S; Elkin, E; Fornier, MN; Ho, AY; Ishill, N; McCormick, B; Montgomery, L	1
Avril, N; Avril-Sassen, S; Dose-Schwarz, J; Jänicke, F; Lebeau, A; Mahner, S; Schwaiger, M; Tiling, R; Untch, M; Weber, C	1
Aoki, T; Hamada, H; Katsuki, Y; Kenno, S; Takada, J	1
Ceraulo, D; Cereda, S; Fugazza, C; Mazza, E; Reni, M; Rognone, A; Villa, E	1
Hanai, K; Hongoh, S; Inatsuchi, H; Kawakami, M; Nomoto, T; Terachi, T	1
Aldrighetti, L; Cereda, S; Nicoletti, R; Passoni, P; Reni, M; Viganò, MG; Villa, E	1
Di Iulio, J; Harvey, J; Jayamoham, J; Joon, DL; Leong, T; Mann, GB; Michael, M; Milner, A; Spry, N; Willis, D	1
Bertheau, P; Brain, E; Delaloge, S; Espié, M; Guinebretière, JM; Marty, M; Mathieu, MC; Pierga, JY; Savignoni, A; Sigal-Zafrani, B; Spielmann, M	1
Gallagher, M; Giantonio, B; Haller, DG; Metz, JM; O'Dwyer, PJ; Sun, W; Whittington, R	1
Archer, C; Beadman, C; Cunningham, D; Gilligan, D; Kurek, R; Oates, J; Rao, S; Ruhstaller, T; Starling, N; Sumpter, K; Valladares-Ayerbes, M; Wilke, H	1
Appleyard, V; Baker, L; Exon, D; Kelly, P; Lamont, D; Murray, K; Paulin, F; Suttie, S; Thompson, A	1
Appadurai, I; Arnold, DT; Blackshaw, G; Crosby, TD; Davies, L; Escofet, X; Evans, M; Gwynne, S; Lewis, WG; Roberts, SA	1
Ashley, SE; Chau, I; Chua, YJ; Cunningham, D; Oates, J; Okines, AF; Saffery, C; Turner, A; Webb, J	1
de Jongh, FE; Eskens, FA; Konings, IR; Sleijfer, S; van der Gaast, A; van der Wijk, LJ	1
Ah-See, ML; Beresford, MJ; Collins, DJ; d'Arcy, JA; Li, SP; Makris, A; Padhani, AR; Stirling, JJ; Taylor, NJ	1
Li, Y; Liu, SP; Liu, SQ; Luo, HS; Peng, CW; Wu, L; Xie, YS; Zhang, YH	1
Gossage, JA; Hale, PC; Mamidanna, R; Manifold, DK; Newman, G; Pantling, AZ; Robinson, A	1
Cheong, KA; Chrystal, K; Harper, PG; Karapetis, CS; Marx, G; Steer, C; Strickland, AH; Yip, D; Yip, S	1
Asghar, U; Ashley, S; Ashton, J; Chau, I; Cunningham, D; Hawkes, E; Jackson, K; Okines, AF	1
Mathew, J; Odell, JA; Stauffer, JA	1
Chu, P; DU, XL; Li, DP; Liu, NF; Lu, CH; Sheng, XG; Zhou, CX	1
Barbour, A; Gotley, DC; Hirst, J; Smithers, BM; Thomas, J	1
Chun, CL; Dormady, S; Eisenstat, S; Lombard, C; Triadafilopoulos, G	1
Cegovnik, U; Kern, I; Korošec, P; Košnik, M; Rijavec, M; Silar, M; Triller, N	1
Bagot, M; Cosnes, A; Duong, TA; Gantzer, A; Ortonne, N; Regnier, S; Wolkenstein, P	1
Chen, Y; Li, H; Liu, DZ; Yan, D; Zeng, HY; Zhou, CW	1
Gilani, SQ; Jain, PK; Pellen, MG; Razack, A; Sabri, S	1
Danso-Appiah, A; Eastwood, A; Norman, G; Palmer, S; Rice, S; Spackman, E; Stirk, L; Suh, D	1
Balzano, G; Belli, C; Cappio, S; Cereda, S; Doglioni, C; Fugazza, C; Ghidini, M; Longoni, S; Nicoletti, R; Passoni, P; Reni, M; Rezzonico, S; Rognone, A; Slim, N; Villa, E	1
Abel, U; Debus, J; Haag, GM; Haberkorn, U; Jäger, D; Lordick, F; Lorenzen, S; Münter, MW; Stange, A; von Gall, C; Weichert, W; Weitz, J	1
Lolkema, MP; van der Horst, S; van der Sluis, PC; van Hillegersberg, R; Verhage, RJ	1
Ashley, S; Chau, I; Cunningham, D; Gujral, DM; Hawkins, MA; Leonulli, BG; Tait, D	1
Bear, R; Coyne, CP; Jones, T	1
Helin, H; Karhumäki, L; Kauppi, JT; Kemppainen, J; Oksala, N; Räsänen, JV; Salo, JA; Sihvo, EI	1
Aprile, G; Balzano, G; Cereda, S; Di Carlo, V; Di Muzio, N; Fugazza, C; Magli, A; Milandri, C; Passoni, P; Reni, M; Rognone, A; Saletti, P; Tronconi, MC; Villa, E; Zerbi, A	1
Bains, S; Madhavarao, B; Mutyala, V; Patil, C	1
Auriemma, A; Bassi, C; Boz, G; Cantore, M; Frigerio, I; Giardino, A; Girelli, R; Mambrini, A; Orlandi, M; Salvia, R	1
Arasaradnam, RP; Borman, RA; Goodyear, SJ; James, S; Jarvie, EM; Nwokolo, CU; Sanger, GJ; Snead, D; Sung, EZ	1
Cho, EK; Chung, M; Hong, J; Jung, M; Kim, HS; Lee, JH; Lee, WK; Park, J; Shin, DB; Sym, SJ	1
Hegg, R; Heinzmann, D; Ismael, G; Jackisch, C; Kim, SB; Lichinitser, M; Lum, B; Melichar, B; Muehlbauer, S; Pienkowski, T; Semiglazov, V	1
Florou, D; Mavridis, K; Scorilas, A	1
Hsu, CY; Lin, HR; Lo, YL	1
Allum, WH; Blazeby, JM; Coxon, F; Cunningham, D; Evans, L; Falk, S; Ford, D; Griffin, M; Hall, M; Iveson, TJ; Langley, RE; Middleton, GW; Okines, AF; Petty, RD; Plummer, C; Seymour, M; Slater, S; Smith, D; Stenning, SP; Stevenson, L; Thompson, LC; Waters, J	1
Ieda, N; Pirovano, C; Siesto, G; Vitobello, D	1
Cunningham, D; Eltahir, Z; Langley, RE; Noor, D; Okines, AF; Reis-Filho, JS; Stenning, S; Thompson, LC; Waddell, TS; Wong, R; Wotherspoon, A	1
Lo, YL	1
Hack, A; Königsrainer, A; Küper, M; Schott, TC; Struller, F; Weinreich, J	1
Cai, G; Li, G; Ma, X; Zhang, Z; Zhu, J	1
Dar, AR; Erickson, AL; Inculet, RI; Malthaner, RA; Palma, DA; Pierce, G; Rodrigues, GB; Yaremko, BP; Yu, E	1
Chiu, HC; Chu, CY; Yang, CH	1
Cini, G; De Luca Cardillo, C; Doni, L; Fioretto, LM; Fulignati, C; Mini, E; Moretti, R; Neri, B; Pantalone, D; Quattrone, A; Ribecco, AS; Scatizzi, M; Turrini, M; Zocchi, G	1
Blackie, R; Evans, TR; Fullarton, GM; McDonald, AC; McInnes, A; Morrison, R; Paul, J; Pentheroudakis, G; Raby, N; Soukop, M	1
Grem, JL; Leonard, GD; Zhuang, SH	1
André, T; Artru, P; Louvet, C	1
Xiao, QM; Zhang, WD; Zhou, JH	1
Dörken, B; Krenn, V; Kretzschmar, A; Reichardt, P; Thuss-Patience, PC	1
Atalay, G; Biganzoli, L; Bonnefoi, H; Cufer, T; Mauriac, L; Piccart, M; Schaefer, P	1
Bisagni, G; Camisa, R; Canaletti, R; Carlini, P; Cocconi, G; Cognetti, F; Di Costanzo, F; Gamboni, A; Gasperoni, S; Porrozzi, S; Pucci, F; Rodinò, C; Ruggeri, EM; Zironi, S	1
Bayram, O; Celenkoglu, G; Cihan, A; Coskun, U; Gunel, N; Onuk, E; Ozkan, S; Ucan, B; Yamac, D; Yildirim, Y; Yilmaz, E	1
Boezen, HM; de Leede, GP; de Vries, EG; Eppinga, P; Erjavec, Z; Groen, HJ; Kramer, H; Strijbos, JH; Van Putten, JW; Wachters, FM	1
Foo, K; Leong, T; Lim Joon, D; Michael, M; Ngan, S; Thomas, R; Thompson, A; Weih, L; Zalcberg, J	1
Holland, IS; Junor, EJ; McGarva, J; McManners, J; White, JD	1
Ho, HS; Ong, HS	1
Nishiura, K; Obata, H; Okugawa, T; Tabata, T; Tanaka, K; Toyoda, N; Yanoh, K	1
Geh, I; Hiller, L; Wilson, D	1
Birtle, AJ; Harland, SJ; Newby, JC	1
Barone, C; Basso, M; Brunetti, IM; Cassano, A; D'Ugo, D; Longo, R; Persiani, R; Picciocchi, A; Pozzo, C; Schinzari, G	1
Dörken, B; Hennesser, D; Kingreen, D; Kretzschmar, A; Micheel, S; Pink, D; Reichardt, P; Repp, M; Scholz, C; Thuss-Patience, PC	1
Byun, JH; Choi, MG; Chung, IS; Hong, YS; Kang, JH; Kim, KW; Lee, KS; Lee, MA; Moon, DH; Park, SY; Shim, BY; Woo, IS	1
Gallagher, M; Giantonio, B; Haller, D; Metz, J; O'Dwyer, P; Sun, W; Whittington, R	1
Becerra, CR	1
Cantore, M; Caudana, R; Ceravolo, C; Comella, G; Del Freo, A; Fiorentini, G; Luppi, G; Mambrini, A; Marangolo, M; Miserocchi, L; Piazza, E; Rabbi, C; Rosati, G; Zamagni, D	1
Cantore, M; Caudana, R; Fiorentini, G; Lombardi, M; Mambrini, A; Nicoli, N; Pennucci, C; Rabbi, C; Sanguinetti, F; Zamagni, D	1
Aldrighetti, L; Balzano, G; Bonetto, E; Bordonaro, R; Cordio, S; Di Carlo, V; Galli, L; Luppi, G; Milandri, C; Nicoletti, R; Oliani, C; Passardi, A; Passoni, P; Reni, M; Staudacher, C; Villa, E; Zerbi, A	1
Arena, MG; Belli, F; Carpano, S; Di Lauro, L; Giannarelli, D; Lopez, M; Paoletti, G	1
Adami, E; Carlini, P; Cognetti, F; De Marco, S; Fariello, AM; Felici, A; Gamucci, T; Gelibter, A; Moscetti, L; Pollera, CF; Ruggeri, EM; Sperduti, I	1
Balzano, G; Bonetto, E; Di Carlo, V; Panucci, MG; Passoni, P; Reni, M; Ronzoni, M; Staudacher, C; Villa, E; Zerbi, A	1
Bang, SM; Cho, EK; Im, SA; Lee, JH; Lee, SN; Lee, WK; Park, DK; Park, SH; Park, YH; Shin, DB	1
Lui, J; Xu, S; Yang, W	1
Barletta, E; Bruni, GS; D'Angelo, R; Daniele, B; Ferrari, E; Fiore, F; Formato, R; Iaffaioli, RV; Ottaiano, A; Pignata, S; Tortoriello, A; Turitto, G	1
Baron, B; Bliss, JM; Conte, PF; Coombes, RC; Couvreur, ML; Crivellari, D; Dos Santos, JG; Emson, M; Fountzilas, G; Hall, E; Homewood, J; Lise, M; Marchet, A; Nitti, D; Sanchez, E; Sava, C; Tres, A; Van Cutsem, E; Wils, J; Woods, E	1
Koulentianos, E; Polyzos, A; Sfikakis, P; Tzianoumis, L	1
Amano, S; Enomoto, K; Kitajima, A; Matsuo, S; Negishi, N; Nemoto, N; Oinuma, T; Sakurai, K	1
Bang, SM; Cho, EK; Lee, JH; Lee, JN; Park, SH; Park, YH; Shin, DB	1
Hoki, M; Hori, S; Ito, T; Iwase, K; Kainuma, S; Kanou, T; Mizuno, H; Mizushima, T; Nakamori, Y; Ozawa, H; Souma, Y; Sugiura, T; Yamanaka, H	1
Atkinson, S; Botha, A; Cheong, K; Chrystal, K; Forshaw, MJ; Gossage, JA; Harper, PG; Mason, RC	1
Brierley, J; Cummings, B; Kassam, Z; Kim, J; Knox, JJ; Lockwood, G; Moore, M; O'brien, C; Oza, A; Ringash, J; Siu, L; Swallow, C; Wong, R	1
Cantore, M; Capelli, P; Fiorentini, G; Iacono, C; Lombardi, M; Mambrini, A; Pacetti, P; Pagani, M; Pederzoli, P; Pulica, C; Serio, G; Torri, T	1
Boot, H; Corporaal, S; Legdeur, MC; Russel, MG; Smit, WM; van der Palen, J	1
Cheong, K; Chrystal, K; Forshaw, MJ; Gossage, JA; Harper, PG; Mason, RC	1
Lago, S; Murad, AM; Pecego, R; Skare, NG; Vinholes, J	1
Aitini, E; Cantore, M; Caudana, R; Ceravolo, C; Comella, G; Del Freo, A; Fiorentini, G; Luppi, G; Mambrini, A; Marangolo, M; Miserocchi, L; Piazza, E; Rosati, G; Zamagni, D	1
Balzano, G; Bonetto, E; Cereda, S; Di Carlo, V; Nicoletti, R; Passoni, P; Reni, M; Staudacher, C; Viganò, MG; Zerbi, A	2
Allum, WH; Chua, YJ; Cunningham, D; Falk, SJ; Iveson, TJ; Langley, RE; Lofts, FJ; Nicolson, M; Scarffe, JH; Smith, DB; Stenning, SP; Thompson, JN; Van de Velde, CJ; Verma, M; Weeden, S	1
Bonetto, E; Bordonaro, R; Cereda, S; Cordio, S; Di Carlo, V; Galli, L; Johnson, CD; Milandri, C; Passoni, P; Reni, M; Spreafico, A; Staudacher, C	1
Barrett-Lee, P; Grieve, R; Houston, S; Howell, A; Johnston, S; Leonard, R; Malinovszky, K; O'Reilly, S; Verrill, M; Wardley, A	1
Arslan, M; Demiray, M; Ercan, I; Evrensel, T; Gokgoz, S; Manavoglu, O; Saraydaroglu, O; Ulukaya, EE	1
Mohagheghi, MA; Montazeri, A; Sadighi, S; Sadighi, Z	1
Giommoni, E; Grifoni, R; Mercatelli, A; Neri, B; Pantaleo, P; Pantalone, D; Paoletti, C; Rotella, V; Taddei, A; Tonelli, P	1
Li, DP; Liu, YL; Song, XR; Wang, XW; Wei, L	1
Baruch, NB; Biran, H; Dinerman, M; Idelevich, E; Karminsky, N; Katsenelson, RL; Man, S; Shani, A; Zvi, NB	1
Dupont, J; Jensen, BV; Jensen, HA; Pfeiffer, P	1
Cartenì, G; Catalano, G; Ciardiello, F; Colucci, G; De Vita, F; Di Martino, N; Galizia, G; Gebbia, V; Giuliani, F; Maiello, E; Manzione, L; Montemurro, F; Orditura, M; Romito, S	1
Cereda, S; Galli, L; Reni, M	1
Chua, YJ; Cunningham, D	1
Briasoulis, E; Fatouros, M; Roukos, DH	1
Bernhard, J; Borner, MM; de Braud, F; Falk, S; Fazio, N; Glynne-Jones, R; Köberle, D; Leslie, M; Maibach, R; Roth, AD; Rufibach, K; Saletti, P; Seymour, M; Stupp, R; Wernli, M; Widmer, L	1
Choi, CW; Choi, IK; Kim, BS; Kim, JS; Kim, SJ; Kim, YH; Oh, SC; Park, KH; Seo, HY; Seo, JH; Shin, SW; Sung, HJ	1
Filip, DJ; Grossniklaus, HE; Lee, WB; Sy, HM	1
Park, KG; Smith, TA; Suttie, SA	1
Aravantinos, G; Fountzilas, G; Gogas, H; Kalofonos, HP; Klouvas, G; Kosmidis, P; Makatsoris, T; Papakostas, P; Pectasides, D; Tsavdaridis, D; Xanthakis, I	1
Ajani, JA; Cen, P	1
Bützow, R; Chen, DT; Desmond, RA; Hemminki, A; Kanerva, A; Raki, M; Särkioja, M	1
Akiyama, F; Horii, R; Ito, Y; Iwase, T; Matsuura, M; Miki, Y	1
Bamias, A; Giannopoulos, A; Gourgoulis, G; Mountzios, G; Papaiakovou, EE; Rodolakis, A; Vlahos, G; Voulgaris, Z	1
Brock, CS; Eccles, S; Francis, N; Lim, A; McLean, SR; Nathan, M; Palmieri, C; Shousha, S	1
Han, JG; Li, BX; Xue, YW; Yang, BF	1
Balduzzi, A; Bottiglieri, L; Colleoni, M; Ghisini, R; Giovanardi, F; Goldhirsch, A; Luini, A; Orlando, L; Rocca, A; Torrisi, R; Veronesi, P; Viale, G	1
Chang, LC; Kuo, KW; Liang, CH; Sheu, HM; Shiu, LY; Tsai, EM	1
Ballardini, M; Bassi, C; Cantore, M; Fiorentini, G; Guadagni, S; Iacono, C; Mambrini, A; Orlandi, M; Pacetti, P; Torri, T	1
Calzolari, F; Cecconetto, L; Giampalma, E; Golfieri, R; Milandri, C; Passardi, A; Tison, C	1
Hamaoka, T; Hayashi, N; Kawasaki, T; Kikuchi, M; Nakamura, S; Suzuki, K; Tsugawa, K; Tsunoda-Shimizu, H; Yagata, H	1
Cho, JY; Choi, SH; Lee, DK; Lee, KS; Lee, SI; Lee, SJ; Lim, JY; Paik, YH; Park, HJ; Yoon, DS	1
Arcidiacono, PG; Balzano, G; Cereda, S; Di Carlo, V; Mazza, E; Nicoletti, R; Passoni, P; Reni, M; Staudacher, C; Zerbi, A	1
Cheng, AL; Hsu, C; Hu, FC; Huang, TC; Kuo, SH; Lin, CC; Shih, JY; Yang, CH; Yang, PC; Yu, CJ	1
Aravantinos, G; Bafaloukos, D; Bozas, G; Dimopoulos, MA; Fountzilas, G; Kalofonos, H; Kosmidis, P; Papadimitriou, CA	1
Andersen, J; Bergh, J; Bjerregaard, B; Cold, S; Edlund, P; Ejlertsen, B; Ewertz, M; Jensen, MB; Kamby, C; Kristensen, B; Lindman, H; Mouridsen, HT; Nordenskjöld, B	1
Hansen, HH; Hansen, M; Joss, RA; Renard, J; Rozencweig, M	1
Ganzina, F	1
Ahmed, T; Benedetto, P; Needles, B; Watson, RC; Yagoda, A	1
Farabegoli, G; Fruet, F; Martoni, A; Pannuti, F; Tomasi, L	1
Bajardi, G; Cannata, G; Cipolla, C; Curto, G; Gebbia, V; Latteri, M; Mastrandrea, G; Pischedda, G; Testa, A; Valenza, R	1
Igawa, M; Kadena, H; Ueda, M; Usui, T	1
Kinouchi, T; Kotake, T; Kuroda, M; Maeda, O; Meguro, N; Saiki, S; Usami, M	1
Harper, PG; Highley, MS; Houston, SJ; Mason, RC; Parnis, FX; Penson, RT; Trotter, GA	1
Chevallier, B; Chollet, P; Fargeot, P; Fizames, C; Fumoleau, P; Genot, JY; Kerbrat, P; Merrouche, Y; Olivier, JP; Roche, H	1
Kudo, C; Saito, M; Yoshida, T	1
Ariga, T; Kinoshita, H; Maruyama, T; Ooshima, I; Ozaki, M; Shimada, H; Shouko, T; Takeda, A; Yoshimura, S	1
Hojyo, M; Koizumi, T; Kosaka, A; Maruo, H; Mori, K; Osaku, M; Watahiki, Y	1
Akiyama, J; Hyogo, H; Ito, K; Kida, M; Kido, S; Kojima, K; Matsuda, M; Matsuura, M; Nakajima, N; Yamamoto, K	1
Egami, I; Onda, M; Yoshida, Y	1
Cabarrot, E; Gedouin, D; Gérard, JP; Goudier, MJ; Héry, M; Jacquin, JP; Monnier, A; Namer, M; Plat, F; Serin, D	1
Babiĭ, IaS; Bolgova, LS; Galakhin, KA; Iugrinov, OG; Klapchuk, AG; Pozmogov, AI; Rodzaevskiĭ, SA; Tuganova, TN	1
Adenis, A	1
Miura, T; Shinohara, K	1
Chacon, I; Colmenarejo, A; Espinosa, E; Feliu, J; García-Girón, C; Garrido, P; González-Barón, M	1
Azhar, T; Cheirsilpa, A; Kang, SB; Lee, HP; Lorvidhaya, V; Manalo, A; Tattersall, MH; Vootiprux, V; Wong, F; Yen, MS	1
Bamias, A; Cunningham, D; Hill, A; Hill, M; Nicolson, M; Nicolson, V; Norman, A; O'Brien, M; Webb, A	1
Bastit, P; Chevallier, B; Couteau, C	1
Fujisawa, J; Satoh, Y; Uchino, J; Une, Y	1
Abad, A; Balañá, C; Camps, C; Font, A; Masuti, B; Sánchez, JJ; Vicent, JM	1
Chlebowski, RT; Harry, D; Loehrer, PJ	1
Ikenaga, M; Kikkawa, N; Kobayashi, K; Mishima, H; Morita, T; Shin, E; Takatsuka, Y; Tamaki, Y; Touno, T; Yagyu, T	1
Cunningham, D; Findlay, M; Ford, H; Hickish, T; Mansi, J; Nash, A; Nicolson, M; Nicolson, V; Norman, A; Sacks, N	1
Akashi, H; Inoue, Y; Mizumoto, S; Nakamura, H; Yamasaki, K; Yano, M	1
Kajanti, M; Pyrhönen, S	1
Chevallier, B; Chollet, P; Hurteloup, P; Olivier, JP; Roche, H	1
Ishikawa, A; Ito, K; Matsuda, M; Matsuura, M; Nakajima, N; Ozawa, M; Suzuki, K; Toyama, K	1
Ciavattini, A; Cignitti, M; Fabris, N; Garzetti, GG; Romanini, C	1
Delanian, S; Housset, M; Marie, JP; Maulard, C	1
Asada, S; Doi, H; Goto, H; Imaeda, T; Kanematsu, M; Matsui, E; Mochizuki, R; Shibayama, M; Yamawaki, Y	1
Depisch, D; Kornek, G; Kwasny, W; Rosen, H; Scheithauer, W; Schulz, F; Sebesta, C	1
Bader, H; Eisenberger, F; Guhl, L; Jipp, P; Nunnensiek, C; Rassweiler, J; Ruether, U; Schmidt, A; Stilz, S	1
Ciavattini, A; Cignitti, M; De Nictolis, M; Garzetti, GG; Goteri, G; Romanini, C; Tranquilli, AL	1
Coombes, RC; Glees, J; Topham, C	1
Aquino, A; Cintorino, M; Francini, G; Manganelli, A; Marsili, S; Mondillo, S; Petrioli, R	1
Bajetta, E; Di Bartolomeo, M; Di Leo, A; Zampino, MG	1
Beith, JM; Bell, D; Levi, JA; Snyder, RD; Tattersall, MH; Wheeler, H	1
Andreoli, F; Borrelli, D; Bruno, L; Cini, G; de Leonardis, V; Fabbroni, S; Intini, C; Neri, B; Pernice, LM; Romano, S; Valeri, A	1
Globits, S; Kornek, G; Pidlich, J; Raderer, M; Scheithauer, W; Schenk, T; Schulz, F; Tetzner, C	1
Dalgleish, AG; Evans, TR; Glees, JP; Knight, MJ; Lofts, FJ; Mansi, JL	1
Ahmed, FY; Bamias, A; Cunningham, D; Evans, TC; Hill, AS; Hill, ME; Nicolson, MC; Nicolson, V; Norman, AR; O'Brien, ME; Watson, M; Webb, A	1
Durante, NM; Eggermont, AM; Kolker, HJ; Loss, WJ; Schellens, JH; Stoter, G; Van de Vrie, W; Verwey, J	1
Karner, J; Kastner, J; Koperna-Mach, K; Kornek, G; Müller, C; Raderer, M; Scheithauer, W; Tetzner, C	1
Bakker, PJ; Bartelsman, JF; Fockens, P; Poorter, RL; Taat, CW; Veenhof, CH	1
Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T	1
Cunningham, D; Findlay, M; Harper, P; Hickish, T; Hill, A; Hughes, M; Iveson, T; Joffe, JK; Mansi, J; Meehan, M; Nicolson, M; Norman, A; O'Brien, M; Oates, J; Scarffe, JH; Underhill, C; Wardley, A; Watson, M; Webb, A	1
Yamazaki, N	1
Chao, D; Harland, SJ	1
Colombo, A; Gabriele, A; Landoni, F; Lissoni, A; Mangioni, C; Perego, P; Zanetta, G	1
Boccardo, F; Canobbio, L; Esposito, M; Granetto, C; Miglietta, L; Vannozzi, MO	1
Koarai, N; Kobayashi, A; Sugizaki, N; Yamaguchi, M	1
Chao, D; Harland, SJ; von Schlippe, M	1
Fiebiger, WC; Hejna, MH; Kornek, GV; Raderer, M; Scheithauer, W; Vorbeck, F; Weinlaender, G	1
Bakker, PJ; Bolis, G; Curran, D; Sahmoud, T; van der Burg, ME; Vermorken, JB	1
Ayabe, H; Hara, S; Hashizume, S; Itoyanagi, N; Oka, T; Shinguu, H; Tagawa, Y; Tooyama, H; Tou, K; Tsuji, H; Yamamoto, S; Yamazumi, K	1
Gabriele, A; Gorga, G; Landoni, F; Lissoni, A; Mangioni, C; Sessa, C; Tumolo, S	1
Bengala, C; Conte, PF; Favre, C; Greco, F; Macchia, P; Mazzoni, A; Menconi, MC; Pazzagli, I; Tibaldi, C; Vanacore, R	1
Abad, A; Antón, A; Aranda, E; Ariza, A; Blanco, E; Carrato, A; Cervantes, A; Dorta, J; Garcia de Paredes, ML; Massuti, B; Maurel, J; Vicent, JM	1
Casucci, D; Frati, L; Gulino, A; Rea, S; Recchia, F; Sica, G	1
Boyages, J; Gurney, H; Harnett, P; Kefford, R	1
Ishibashi, T; Kaneko, M; Kitada, H; Kobayashi, T; Kohyama, A; Kuwae, C; Minaguchi, R; Ohtsuka, H; Ono, I	1
Baba, M; Hashimoto, K; Hoshida, Y; Ishida, H; Kawasaki, T; Masutani, S; Miya, A; Morimoto, O; Satomi, T; Tatsuta, M; Tsuji, Y; Yoshimura, H; Yoshioka, H	1
Caroli-Bosc, FX; Caujolle, C; Delmont, JP; Demarquay, JF; Gastaud, P; Montoya, ML	1
Kawabata, Y; Nio, Y; Ohishi, T; Sumi, S; Tamura, K; Yano, S	1
Arnoud, L; Belichard, C; Coudert, B; Darut-Jouve, A; Guerrin, J; Jolimoy, G	1
Chao, HT; Juang, CM; Ng, HT; Wang, PH; Yuan, CC	1
Chen, Z; Li, G; Liu, F	1
Daskalakis, A; Lange, W; Musahl, V; von Lintig, F; Waller, CF	1
Choi, CW; Chun, HJ; Hyun, JH; Kim, BS; Kim, JS; Kim, YH; Seo, JH	1
Bareck, E; Depisch, D; Funovics, J; Hejna, M; Kornek, GV; Kovats, E; Lang, F; Miholic, J; Raderer, M; Scheithauer, W; Valencak, J	1
Hirokawa, K; Miyamoto, T; Saiwai, S; Tashiro, T; Usuki, N	1
Bonavina, L; Incarbone, R; Peracchia, A; Via, A	1
Endo, S; Itakura, M; Minari, Y; Nio, Y; Tamura, K; Yamasawa, K; Yano, S	1
Chang, FY; Chao, Y; Chi, KH; Hung, HC; King, KL; Li, CP; Teng, HC; Yen, SH	1
Anthony, DA; Eatock, MM; El-Abassi, M; Evans, TR; Paul, J; Smith, M; Soukop, M; Wilson, P	1
Cantore, M; Ceravolo, C; Cornalba, G; Fiorentini, G; Frassoldati, A; Guadagni, S; Miserocchi, L; Muchmore, JH; Pederzoli, P; Smerieri, F	1
Dai, A; Feng, J; Zheng, X	1
Banerji, U; Geh, JI; Glynne-Jones, R; Harrison, RA; Kwok, QS; Livingstone, JI; Mitchell, IC; Townsend, ER	1
Chen, Y; Lin, WC; Perng, RP; Tsai, CM; Whang-Peng, J; Wu, HW; Yang, KY	1
Angelelli, B; Bovicelli, A; Ceccarelli, C; Costa, S; Erzén, M; Lipponen, P; Martoni, A; Santini, D; Syrjänen, K; Syrjänen, S; Terzano, P	1
Akiyama, N; Ishizaki, M; Motegi, M; Nakajima, M; Osawa, H; Sasamoto, H; Tanaka, S; Wada, W	1
Andreoli, F; Boffi, B; Cini, G; Francesconi, D; Mazzanti, R; Medi, F; Mercatelli, A; Moretti, R; Neri, B; Romano, S; Siliani, L; Tarquini, R	1
Harper, PG; Karapetis, CS; Strickland, AH; Yip, D	1
Balzano, G; Di Carlo, V; Galli, L; Nicoletti, R; Panucci, MG; Passoni, P; Reni, M; Villa, E; Zerbi, A	1
De Filippis, S; Pompili, PL; Rea, S; Recchia, F; Rosselli, M; Sica, G	1
Borel, C; Escande, A; Ghnassia, JP; Haegelé, P; Mors, R; Petit, T; Rodier, JF	1
Carpini, RD; Fedier, A; Fink, D; Haller, U; Schwarz, VA; Walt, H	1
Hirakawa, K; Nakazawa, K; Nishihara, T; Nishino, H; Tamamori, Y; Tanaka, H; Yamada, N	1
Evans, TR; Fullarton, GM; Garcia-Vargas, J; Harris, AL; Lofts, FJ; Mackay, HJ; McDonald, AC; McInnes, A; Paul, J; Raby, N; Soukop, M	1
Cowling, M; Harper, PG; Karapetis, CS; Ryder, K; Strickland, A; Virik, K; Yip, D	1
Aronne, T; Caliò, E; Franchi, F; Gargano, L; Pagani Guazzugli Bonaiuti, V; Sbaffi, E; Seminara, P	1
Peng, ZH; Qiu, GQ; Tang, HM; Xing, TH	1
Argyle, DJ; Cave, TA; Hine, R; Howie, F; Thompson, H	1
Bruckner, HW; Kozuch, P; Petryk, M	1
Alftan, H; Lehtovirta, P; Leminen, A; Stenman, UH	1
Bender, HG; Michel, RT; Mitze, M; Stegmüller, M; Vering, A	1
Fujii, S	1
Benjachai, W; Cheirsilpa, A; Kosiyatrakul, T; Puriphat, S; Tangkrutt, S	1
Aoki, K; Nose, H; Okada, S; Okazaki, N; Saitoh, D; Shimada, Y; Shirao, K; Tajiri, H; Yokota, T; Yoshida, S	1
Dick, R; Dusheiko, G; Hobbs, KE; Markham, NI; Novell, JR; Reddy, K	1
Carpano, S; Conti, EM; Di Lauro, L; Lopez, M; Natali, M; Tonini, G; Vici, P	1
Bachy, B; Caillaud, JM; Flamant, F; Gruner, M; Hemet, J; Lefur, R; Lemerle, J; Tron, P; Vannier, JP	1
Astone, A; Barone, C; Cassano, A; Fontana, T; Garufi, C; Grieco, A; Noviello, MR; Pacelli, F; Ricevuto, E	1
Armas, A; Asins-Codoñer, E; Calero, F; Díaz-Castellanos, R; Garzón, J; Iglesias, J; Jimeno, J; Matía, F; Mendaña, J; Rodriguez Escudero, F	1
Ulmer, W	1
Abe, R; Hoshino, M; Koyama, Y; Satou, N	1
Avril, A; Dilhuydy, JM; Durand, M; Mauriac, L	1
Kolarić, K; Luetić, J; Roth, A; Zupanc, D	1
Ban, J; Bistrović, M; Dujmović, I; Kolarić, K; Roth, A	1
Airoldi, M; Brando, V; Gabriele, P; Giordano, C; Pedani, F	1
Blum, RH; Lafleur, F; Molinaro, P	1
Bleiberg, H; Buyse, M; Duez, N; Herben, M; Splinter, T; Veenhof, C; Wagener, DT; Wils, J	1
Aitokallio-Tallberg, A; Viinikka, L; Ylikorkala, O	1
Frederiksen, PL; Oxholm, A; Oxholm, P	1
Damber, JE; Landström, M; Tomić, R	1
Arai, R; Fukuoka, M; Furuse, K; Hayashi, S; Kawahara, M; Kiyota, M; Kodama, N; Kubota, K; Tsuruta, M; Yamamoto, M	1
Abad-Esteve, A; Fernandez, C; Monras, P; Moreno, I; Morera, J; Ribas-Mundo, M; Rosell, R; Ruiz, J	1
Aeikens, B; de Riese, W; Lenis, G; Schindler, E	1
Algamiz, C; Badano, C; Bruno, M; Cazap, E; Chacon, R; Desimone, G; Estevez, R; Levy, D; Roca, E; Romero, A	1
Hayakawa, M; Hayashi, T; Kano, H; Kimura, K; Morise, K; Nagano, I; Nakai, T; Sakakibara, K; Suga, S; Yokoyama, Y	1
Carter, DC; Cunningham, D; Jack, A; Kaye, SB; McArdle, CS; McMurdo, DF; Soukop, M	1
Bleiberg, H; Blijham, G; Dalesio, O; Duez, N; Planting, A; Splinter, T; Weber, W; Wils, J	1
Bleiberg, H; Blijham, G; Dalesio, O; Duez, N; Lacave, A; Splinter, T; Wils, J	1
Giles, GR; Johnson, RJ; Kenny, JB; Leveson, SH; Maley, WV; Owens, SE; Scarffe, JH	1

Reviews

13 review(s) available for epirubicin and Adenocarcinoma, Basal Cell

Article	Year
Chemotherapy plus estramustine for management of castration-resistant prostate cancer: meta-analysis of randomized controlled trials. Actas urologicas espanolas, 2014, Volume: 38, Issue:3 Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Combined Modality Therapy; Docetaxel; Epirubicin; Epothilones; Estramustine; Fatigue; Gastrointestinal Diseases; Hematologic Diseases; Humans; Male; Orchiectomy; Paclitaxel; Peripheral Nervous System Diseases; Prostate-Specific Antigen; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Salvage Therapy; Survival Analysis; Taxoids; Treatment Outcome; Vinblastine	2014
Treatment options in patients with metastatic gastric cancer: current status and future perspectives. World journal of gastroenterology, 2014, Apr-14, Volume: 20, Issue:14 Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cisplatin; Clinical Trials as Topic; Docetaxel; Epirubicin; Fluorouracil; Humans; Medical Oncology; Neoplasm Metastasis; Palliative Care; Pyrimidines; Quality of Life; Receptor, ErbB-2; Stomach Neoplasms; Taxoids; Trastuzumab; Treatment Outcome; Vascular Endothelial Growth Factor A	2014
[Subacute cutaneous lupus erythematosus and cancer: two cases and literature review]. Annales de dermatologie et de venereologie, 2011, Volume: 138, Issue:5 Topics: Adenocarcinoma; Aged; Antibodies, Antinuclear; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Autoantigens; Bevacizumab; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous; Mastectomy; Middle Aged; Paclitaxel; Paraneoplastic Syndromes; Ribonucleoproteins; Salvage Therapy; Tamoxifen; Taxoids; Trastuzumab	2011
Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction. Health technology assessment (Winchester, England), 2011, Volume: 15 Suppl 1 Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Capecitabine; Cisplatin; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Fluorouracil; Humans; In Situ Hybridization, Fluorescence; Meta-Analysis as Topic; Multicenter Studies as Topic; Neoplasm Metastasis; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Stomach Neoplasms; Trastuzumab	2011
[Gemcitabine-based combinations in inoperable pancreatic cancers]. Bulletin du cancer, 2002, Volume: 89 Spec No Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Cisplatin; Clinical Trials, Phase II as Topic; Deoxycytidine; Docetaxel; Drug Administration Routes; Epirubicin; Fluorouracil; Gemcitabine; Humans; Irinotecan; Multicenter Studies as Topic; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Palliative Care; Pancreatic Neoplasms; Randomized Controlled Trials as Topic; Taxoids; Treatment Outcome	2002
Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Randomized Controlled Trials as Topic; Stomach Neoplasms; Survival Analysis	2006
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: the ghost regimen. Cancer letters, 2007, Oct-18, Volume: 256, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Epirubicin; Fluorouracil; Gemcitabine; Humans; Pancreatic Neoplasms; Survival Rate	2007
Medical treatment for advanced gastroesophageal adenocarcinoma. Current opinion in gastroenterology, 2007, Volume: 23, Issue:6 Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Clinical Trials, Phase III as Topic; Deoxycytidine; Drug Combinations; Epirubicin; Esophageal Neoplasms; Fluorouracil; Humans; Oxonic Acid; Stomach Neoplasms; Tegafur; Treatment Outcome	2007
4'-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data. Cancer treatment reviews, 1983, Volume: 10, Issue:1 Topics: Adenocarcinoma; Animals; Breast Neoplasms; Chemical Phenomena; Chemistry; Colonic Neoplasms; Dogs; Doxorubicin; Epirubicin; Female; Heart; Humans; Kidney Neoplasms; Male; Melanoma; Mutagenicity Tests; Neoplasms, Experimental; Rabbits	1983
[Chemotherapy for advanced adenocarcinoma of the skin: experience with combination chemotherapy and a review of the literature]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Epirubicin; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Paget Disease, Extramammary; Skin Neoplasms; Sweat Gland Neoplasms; Vincristine	1997
[A case of solitary metastatic splenic tumor of ovarian carcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:10 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Humans; Hysterectomy; Irinotecan; Ovarian Neoplasms; Splenectomy; Splenic Neoplasms	1997
[A case of gastric cancer with multiple liver metastases that were completely responsive to hepatic arterial infusion chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:11 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Remission Induction; Stomach Neoplasms	2001
A comprehensive update on the use of chemotherapy for metastatic pancreatic adenocarcinoma. Hematology/oncology clinics of North America, 2002, Volume: 16, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Camptothecin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Docetaxel; Enzyme Inhibitors; Epirubicin; Fluorouracil; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Interferon alpha-2; Interferon-alpha; Irinotecan; Leucovorin; Multicenter Studies as Topic; Organoplatinum Compounds; Paclitaxel; Palliative Care; Pancreatic Neoplasms; Recombinant Proteins; Respiratory Distress Syndrome; Taxoids; Treatment Outcome	2002

Trials

145 trial(s) available for epirubicin and Adenocarcinoma, Basal Cell

Article	Year
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers. Gut, 2021, Volume: 70, Issue:9 Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Epirubicin; ErbB Receptors; Esophageal Neoplasms; Humans; Male; Middle Aged; Panitumumab; Stomach Neoplasms	2021
Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinoma. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2021, Volume: 24, Issue:3 Topics: Adenocarcinoma; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Claudins; Epirubicin; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Oxaliplatin; Patient Reported Outcome Measures; Progression-Free Survival; Stomach Neoplasms; Surveys and Questionnaires; Treatment Outcome	2021
TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG. Annals of surgical oncology, 2017, Volume: 24, Issue:8 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Perioperative Care; Preoperative Care; Prognosis; Stomach Neoplasms; Survival Rate	2017
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Nov-10, Volume: 35, Issue:32 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Epirubicin; Esophagogastric Junction; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Risk Factors; Stomach Neoplasms; Survival Rate; Treatment Outcome; United States	2017
Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/ European journal of cancer (Oxford, England : 1990), 2018, Volume: 93 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Cisplatin; Combined Modality Therapy; Epirubicin; ErbB Receptors; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Neoadjuvant Therapy; Panitumumab; Perioperative Care; Prognosis; Societies, Medical; Stomach Neoplasms; Survival Rate	2018
Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019, Volume: 22, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Epirubicin; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate	2019
The Effect of Supplementary Omegaven® on the Clinical Outcome of Patients With Advanced Esophagogastric Adenocarcinoma Receiving Palliative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy: A Phase II clinical trial. Anticancer research, 2019, Volume: 39, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Capecitabine; Cell Proliferation; Cytokines; Dietary Supplements; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Fatty Acids, Omega-3; Feasibility Studies; Female; Fish Oils; Humans; Male; Middle Aged; Oxaliplatin; Palliative Care; Pilot Projects; Prospective Studies; Stomach Neoplasms; Treatment Outcome; Triglycerides	2019
Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro-oesophageal junction. The British journal of surgery, 2019, Volume: 106, Issue:9 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Cisplatin; Clinical Protocols; Combined Modality Therapy; Epirubicin; Esophagogastric Junction; Gastrectomy; Humans; Quality Assurance, Health Care; Stomach; Stomach Neoplasms	2019
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial. The Lancet. Oncology, 2013, Volume: 14, Issue:6 Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Chi-Square Distribution; Deoxycytidine; Disease-Free Survival; Early Termination of Clinical Trials; Epirubicin; ErbB Receptors; Esophageal Neoplasms; Female; Fluorouracil; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Molecular Targeted Therapy; Multivariate Analysis; Odds Ratio; Organoplatinum Compounds; Oxaliplatin; Panitumumab; Proportional Hazards Models; Protein Kinase Inhibitors; Stomach Neoplasms; Time Factors; Treatment Outcome; United Kingdom	2013
A phase I trial of bortezomib in combination with epirubicin, carboplatin and capecitabine (ECarboX) in advanced oesophagogastric adenocarcinoma. Investigational new drugs, 2014, Volume: 32, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carboplatin; Deoxycytidine; Epirubicin; Female; Gastrointestinal Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Proteasome Inhibitors; Pyrazines	2014
A multicenter phase I-II study of docetaxel plus epirubicin plus bevacizumab as first-line treatment in women with HER2-negative metastatic breast cancer. Breast (Edinburgh, Scotland), 2013, Volume: 22, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Anemia; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Diarrhea; Disease-Free Survival; Docetaxel; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplastic Cells, Circulating; Neutropenia; Receptor, ErbB-2; Survival Rate; Taxoids; Thrombocytopenia; Young Adult	2013
Adding preoperative radiotherapy plus cetuximab to perioperative chemotherapy for resectable esophageal adenocarcinoma: a single-center prospective phase II trial. The oncologist, 2014, Volume: 19, Issue:1 Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cetuximab; Chemoradiotherapy; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Perioperative Care; Preoperative Care; Prospective Studies; Survivors	2014
Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study. The Lancet. Oncology, 2014, Volume: 15, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Confidence Intervals; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Epirubicin; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Proportional Hazards Models; Stomach Neoplasms; Survival Rate; Treatment Outcome	2014
A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesoph Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2014, Volume: 9, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Cisplatin; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin	2014
Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestive, Féd Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Nov-01, Volume: 32, Issue:31 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; France; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Prospective Studies; Quality of Life; Stomach Neoplasms; Survival Analysis; Treatment Outcome	2014
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience. Cancer chemotherapy and pharmacology, 2015, Volume: 75, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids	2015
Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial. Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:10 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Disease-Free Survival; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Receptor, ErbB-2; Stomach Neoplasms	2015
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 08-10, Volume: 34, Issue:23 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Class I Phosphatidylinositol 3-Kinases; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); PTEN Phosphohydrolase; Receptor, ErbB-2; Stomach Neoplasms; Survival Rate; Tumor Suppressor Protein p53	2016
CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 08-10, Volume: 34, Issue:23 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Disease Progression; Disease-Free Survival; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Survival Rate; Time Factors; Treatment Failure	2016
A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO). British journal of cancer, 2017, Feb-14, Volume: 116, Issue:4 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Disease Progression; Epirubicin; Esophageal Neoplasms; Feasibility Studies; Female; Fluorouracil; Frail Elderly; Humans; Male; Organoplatinum Compounds; Oxaliplatin; Palliative Care	2017
Phase I dose escalation study with irinotecan, capecitabine, epirubicin, and granulocyte colony-stimulating factor support for patients with solid malignancies. American journal of clinical oncology, 2008, Volume: 31, Issue:3 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Camptothecin; Capecitabine; Deoxycytidine; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Synergism; Epirubicin; Female; Fluorouracil; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Infusions, Intravenous; Irinotecan; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Topoisomerase II Inhibitors; Treatment Outcome	2008
tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation. British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Gemcitabine; Heart; Heart Function Tests; Humans; Liver; Liver Function Tests; Lung; Paclitaxel; Prospective Studies; Respiratory Function Tests; Survival Rate	2008
Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer. British journal of cancer, 2008, Sep-16, Volume: 99, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Disease-Free Survival; Epirubicin; Esophagogastric Junction; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Survival Rate; Time Factors; Treatment Outcome; Young Adult	2008
Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer. British journal of cancer, 2008, Sep-16, Volume: 99, Issue:6 Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epirubicin; ErbB Receptors; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Stomach Neoplasms; Survival Rate; Tissue Distribution; Treatment Outcome	2008
Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma. Journal of experimental & clinical cancer research : CR, 2009, Mar-09, Volume: 28 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Epirubicin; Esophagogastric Junction; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Survival Rate; Taxoids	2009
Phase II study of epirubicin in combination with weekly docetaxel for patients with advanced NSCLC who have failed or relapsed after the frontline platinum-based chemotherapy. American journal of clinical oncology, 2009, Volume: 32, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Docetaxel; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Salvage Therapy; Survival Rate; Taxoids; Treatment Failure	2009
Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma. Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:6 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Capecitabine; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease Progression; Disease-Free Survival; Drug Therapy, Combination; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Pancreatic Neoplasms; Survival Analysis; Treatment Failure; Treatment Outcome	2009
A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma. British journal of cancer, 2009, Jun-02, Volume: 100, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease Progression; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Rate	2009
Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan. Breast cancer (Tokyo, Japan), 2010, Volume: 17, Issue:3 Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Japan; Lymphatic Metastasis; Methotrexate; Middle Aged; Receptors, Estrogen; Survival Rate; Treatment Outcome; Young Adult	2010
FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG). Breast cancer research and treatment, 2010, Volume: 119, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Time Factors; Treatment Outcome	2010
[Epirubicin combined with DDP and 5-Fu for treatment of advanced gastric cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Neutropenia; Palliative Care; Retrospective Studies; Stomach Neoplasms; Survival Rate; Thrombocytopenia	2009
Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer. British journal of cancer, 2010, Jan-05, Volume: 102, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Magnetic Resonance Imaging; Mammography; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Mammary	2010
Weekly epirubicin as salvage therapy in patients with gemcitabine-resistant advanced pancreatic cancer. Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:6 Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Deoxycytidine; Disease-Free Survival; Drug Resistance, Neoplasm; Epirubicin; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Salvage Therapy	2009
Adjuvant chemoradiation for gastric cancer using epirubicin, cisplatin, and 5-fluorouracil before and after three-dimensional conformal radiotherapy with concurrent infusional 5-fluorouracil: a multicenter study of the Trans-Tasman Radiation Oncology Grou International journal of radiation oncology, biology, physics, 2011, Mar-01, Volume: 79, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Australia; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Feasibility Studies; Female; Fluorouracil; Humans; Male; Middle Aged; Prospective Studies; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Stomach Neoplasms	2011
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients. Breast cancer research and treatment, 2010, Volume: 122, Issue:2 Topics: Adenocarcinoma; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Celecoxib; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; France; Humans; In Situ Hybridization, Fluorescence; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Pyrazoles; Receptor, ErbB-2; Sulfonamides; Taxoids; Therapeutics; Time Factors; Trastuzumab	2010
Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomas. Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Infusions, Intravenous; Irinotecan; Male; Maximum Tolerated Dose; Middle Aged	2011
Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms; Survival Rate	2010
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: dose-finding study for the prospective multicenter, randomized, phase II/III REAL-3 trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Sep-01, Volume: 28, Issue:25 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Panitumumab; Stomach Neoplasms	2010
The addition of pravastatin to chemotherapy in advanced gastric carcinoma: a randomised phase II trial. European journal of cancer (Oxford, England : 1990), 2010, Volume: 46, Issue:18 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pravastatin; Stomach Neoplasms	2010
A phase I and II trial of epirubicin, cisplatin, 24-hour infusion 5 fluorouracil and sodium folinate in patients with advanced esophagogastric carcinomas. Asia-Pacific journal of clinical oncology, 2010, Volume: 6, Issue:4 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Epirubicin; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Stomach Neoplasms; Survival Rate; Treatment Outcome; Vitamin B Complex	2010
[Gemcitabine based combination chemotherapy, a new salvage regimen for recurrent platinum resistant epithelial ovarian cancer]. Zhonghua fu chan ke za zhi, 2010, Volume: 45, Issue:11 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Resistance, Neoplasm; Epirubicin; Female; Gemcitabine; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Ovarian Neoplasms; Platinum Compounds; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome	2010
A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen). Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neutropenia; Pancreatic Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2012
Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial. Annals of surgical oncology, 2012, Volume: 19, Issue:7 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Prognosis; Survival Rate; Young Adult	2012
Phase I study of 3-weekly combination chemotherapy using epirubicin, oxaliplatin, and S-1 (EOS) in patients with previously untreated advanced gastric cancer. Cancer chemotherapy and pharmacology, 2012, Volume: 70, Issue:2 Topics: Adenocarcinoma; Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Epirubicin; Female; Humans; Injections, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Prospective Studies; Stomach Neoplasms; Tegafur; Young Adult	2012
Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial. The Lancet. Oncology, 2012, Volume: 13, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Infusions, Subcutaneous; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Receptor, ErbB-2; Trastuzumab; Young Adult	2012
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:3 Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Myocardial Infarction; Stomach Neoplasms; Stroke Volume; Thromboembolism; Treatment Outcome	2013
Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Perioperative Period; Prognosis; Receptor, ErbB-2; Stomach Neoplasms; Young Adult	2013
Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: a multicenter phase II study. British journal of cancer, 2002, Aug-27, Volume: 87, Issue:5 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Deoxycytidine; DNA Damage; Drug Administration Schedule; Epirubicin; Female; Gemcitabine; Hematologic Diseases; Humans; Male; Middle Aged; Pancreatic Neoplasms; Survival Analysis; Treatment Outcome	2002
A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Confidence Intervals; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Palliative Care; Probability; Severity of Illness Index; Stomach Neoplasms; Survival Analysis; Treatment Outcome; United Kingdom	2002
Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxel and 5-FU continuous infusion. Onkologie, 2003, Volume: 26, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cisplatin; Docetaxel; Epirubicin; Fluorouracil; Humans; Infusions, Intravenous; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Spleen; Splenic Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome	2003
An EORTC phase I study of capecitabine (Xeloda) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer. European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:9 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Patient Compliance; Treatment Outcome	2003
Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Confidence Intervals; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Italy; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Probability; Prognosis; Stomach Neoplasms; Survival Analysis; Treatment Outcome	2003
First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial. British journal of cancer, 2003, Oct-06, Volume: 89, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Epirubicin; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Quality of Life; Survival Rate; Treatment Outcome	2003
Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin/cisplatin/5-fluorouracil (ECF) and alternative regimens before and after chemoradiation. British journal of cancer, 2003, Oct-20, Volume: 89, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Neoadjuvant Therapy; Radiotherapy, Conformal; Stomach Neoplasms	2003
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer. Oncology, 2004, Volume: 67, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Glucuronates; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Pilot Projects; Stomach Neoplasms; Survival Analysis; Time Factors; Treatment Outcome	2004
Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jan-20, Volume: 23, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2005
A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:1 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Combinations; Epirubicin; Female; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Rate; Tegafur; Uracil	2005
Concurrent RT with 5-FU/epirubicin and cisplatin or irinotecan for locally advanced upper GI adenocarcinoma. Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:14 Suppl 1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Irinotecan; Male; Middle Aged; Radiotherapy, Adjuvant; Treatment Outcome; Upper Gastrointestinal Tract	2004
Irinotecan, epirubicin, and capecitabine in metastatic adenocarcinomas: preliminary results of a phase I study. Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:14 Suppl 1 Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Irinotecan; Male; Treatment Outcome	2004
Gemcitabine versus FLEC regimen given intra-arterially to patients with unresectable pancreatic cancer: a prospective, randomized phase III trial of the Italian Society for Integrated Locoregional Therapy in Oncology. Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Pancreatic Neoplasms; Survival Analysis; Treatment Outcome	2004
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial. The Lancet. Oncology, 2005, Volume: 6, Issue:6 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Infusions, Intravenous; Italy; Male; Middle Aged; Palliative Care; Pancreatic Neoplasms; Survival Analysis; Treatment Outcome	2005
Epirubicin, cisplatin and docetaxel combination therapy for metastatic gastric cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Taxoids	2005
Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study. Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Stomach Neoplasms; Time Factors	2006
Final results of a prospective trial of a PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) regimen followed by radiotherapy after curative surgery for pancreatic adenocarcinoma. Oncology, 2005, Volume: 68, Issue:2-3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease-Free Survival; Epirubicin; Feasibility Studies; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome	2005
A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer. Oncology, 2005, Volume: 68, Issue:4-6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Stomach Neoplasms; Survival Rate; Treatment Outcome	2005
Second-line intra-arterial chemotherapy in advanced pancreatic adenocarcinoma. Frontiers in bioscience : a journal and virtual library, 2006, Jan-01, Volume: 11 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carboplatin; Disease Progression; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Retrospective Studies; Time Factors; Treatment Outcome	2006
Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma. Cancer, 2006, Jan-15, Volume: 106, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Treatment Outcome	2006
Adjuvant intra-arterial 5-fluoruracil, leucovorin, epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma. Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Infusions, Intra-Arterial; Karnofsky Performance Status; Leucovorin; Male; Middle Aged; Pancreatic Neoplasms	2006
Symptomatic responses to neoadjuvant chemotherapy for carcinoma of the oesophagus and oesophagogastric junction: are they worth measuring? Clinical oncology (Royal College of Radiologists (Great Britain)), 2006, Volume: 18, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Decision Making; Deglutition; Disease Progression; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Treatment Outcome; Weight Gain	2006
Phase II multicenter trial of docetaxel, epirubicin, and 5-fluorouracil (DEF) in the treatment of advanced gastric cancer: a novel, safe, and active regimen. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2006, Volume: 9, Issue:2 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Rate; Taxoids	2006
Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer. Journal of experimental & clinical cancer research : CR, 2003, Volume: 22, Issue:4 Suppl Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Infusions, Intra-Arterial; Leucovorin; Male; Middle Aged; Pancreatic Neoplasms; Survival Analysis; Treatment Outcome	2003
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma. Cancer chemotherapy and pharmacology, 2007, Volume: 59, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Survival Rate	2007
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. The New England journal of medicine, 2006, Jul-06, Volume: 355, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Perioperative Care; Stomach Neoplasms; Survival Rate	2006
Quality of life assessment in advanced pancreatic adenocarcinoma: results from a phase III randomized trial. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2006, Volume: 6, Issue:5 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Pancreatic Neoplasms; Quality of Life	2006
TEXAS (Taxotere EXperience with Anthracyclines Study) trial: mature results of activity/toxicity of docetaxel given with anthracyclines in a community setting, as first line therapy for MBC. Cancer chemotherapy and pharmacology, 2007, Volume: 59, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Docetaxel; Doxorubicin; Epirubicin; Female; Hospitals, Community; Humans; Middle Aged; Survival Rate; Taxoids; United Kingdom	2007
Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF). BMC cancer, 2006, Dec-05, Volume: 6 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Stomach Neoplasms; Survival Rate; Taxoids	2006
Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study. British journal of cancer, 2007, Apr-10, Volume: 96, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prognosis; Survival Rate	2007
Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer. Acta oncologica (Stockholm, Sweden), 2007, Volume: 46, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms; Survival Analysis; Tegafur; Time Factors; Treatment Outcome; Uracil	2007
Phase I study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first line therapy in patients with non-resectable gastric cancer. Acta oncologica (Stockholm, Sweden), 2007, Volume: 46, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Denmark; Deoxycytidine; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Severity of Illness Index; Stomach Neoplasms; Survival Analysis; Time Factors; Treatment Outcome	2007
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study). Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Stomach Neoplasms	2007
Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Aug-01, Volume: 25, Issue:22 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Quality of Life; Stomach Neoplasms; Taxoids; Treatment Outcome	2007
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding study. Cancer investigation, 2007, Volume: 25, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Middle Aged; Pancreatic Neoplasms	2007
Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II study. Medical oncology (Northwood, London, England), 2007, Volume: 24, Issue:3 Topics: Adenocarcinoma; Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Male; Middle Aged; Severity of Illness Index; Statistics, Nonparametric; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2007
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel. Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:4 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Preoperative Care; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Remission Induction	2008
Prognostic factors in patients with advanced pancreatic adenocarcinoma treated with intra-arterial chemotherapy. Pancreas, 2008, Volume: 36, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Male; Middle Aged; Pain; Pancreatic Neoplasms; Prognosis; Survival Rate	2008
Intra-arterial chemotherapy of advanced pancreatic cancer: a single center experience. Hepato-gastroenterology, 2007, Volume: 54, Issue:80 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Cancer, Regional Perfusion; Disease Progression; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Treatment Outcome	2007
Salvage chemotherapy with docetaxel and epirubicin for advanced/metastatic gastric cancer. Oncology, 2007, Volume: 73, Issue:1-2 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hematologic Diseases; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Platinum Compounds; Salvage Therapy; Severity of Illness Index; Stomach Neoplasms; Taxoids; Treatment Outcome	2007
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapy. American journal of clinical oncology, 2008, Volume: 31, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug-Related Side Effects and Adverse Reactions; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Pancreatic Neoplasms; Salvage Therapy; Survival Analysis	2008
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trial. Lung cancer (Amsterdam, Netherlands), 2008, Volume: 62, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; DNA Topoisomerases, Type II; DNA-Binding Proteins; Endonucleases; Epirubicin; Female; Gemcitabine; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Treatment Outcome	2008
Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study. Gynecologic oncology, 2008, Volume: 110, Issue:1 Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Endometrial Neoplasms; Epirubicin; Female; Greece; Humans; Injections, Intravenous; Middle Aged; Neoplasm Staging; Paclitaxel; Patient Selection; Recurrence	2008
Bisphosphonate treatment in primary breast cancer: results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer. Acta oncologica (Stockholm, Sweden), 2008, Volume: 47, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Diphosphonates; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Pamidronate	2008
Combination chemotherapy of 5-fluorouracil, epidoxorubicin and mitomycin C in the palliative treatment of locally advanced and/or metastatic adenocarcinoma of the stomach. Journal of chemotherapy (Florence, Italy), 1994, Volume: 6, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Palliative Care; Stomach Neoplasms	1994
M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen. Cancer chemotherapy and pharmacology, 1994, Volume: 35 Suppl Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Kidney Neoplasms; Kidney Pelvis; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Recombinant Proteins; Tomography, X-Ray Computed; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine; World Health Organization	1994
Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer. Cancer chemotherapy and pharmacology, 1994, Volume: 35 Suppl Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cystectomy; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Japan; Male; Methotrexate; Middle Aged; Survival Rate; Urinary Bladder Neoplasms; Vinblastine	1994
Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinoma. The British journal of surgery, 1994, Volume: 81, Issue:12 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Laser Therapy; Male; Middle Aged; Palliative Care; Prognosis; Stomach Neoplasms; Survival Analysis	1994
Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:7 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Double-Blind Method; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Infections; Lenograstim; Middle Aged; Neutropenia; Pharmaceutical Vehicles; Recombinant Proteins; Thrombocytopenia	1995
[Experience in intra-hepatic-arterial chemotherapy and hepatic resection for metastatic colorectal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:11 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Prognosis	1995
[Outcomes of effective treatment of cases of metastatic liver tumors by intra-arterial infusion chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:11 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms; Treatment Outcome	1995
Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study Group. Drugs, 1993, Volume: 45 Suppl 2 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Postmenopause; Survival Rate; Tamoxifen; Treatment Outcome	1993
Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Humans; Middle Aged; Pelvis; Radiotherapy Dosage; Time Factors; Uterine Cervical Neoplasms	1995
Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study. British journal of cancer, 1995, Volume: 71, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Stomach Neoplasms	1995
5-fluorouracil vs. epirubicin vs. 5-fluorouracil plus epirubicin in advanced gastric carcinoma. Investigational new drugs, 1994, Volume: 12, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Digestive System; Drug Synergism; Epirubicin; Female; Fluorouracil; Humans; Longitudinal Studies; Male; Middle Aged; Radionuclide Angiography; Stomach Neoplasms; Survival Rate	1994
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cisplatin; Drug Administration Schedule; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Prognosis; Regression Analysis; Remission Induction; Stomach Neoplasms; Survival Rate	1994
Epirubicin-sequential methotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A phase II study. American journal of clinical oncology, 1994, Volume: 17, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Biliary Tract Neoplasms; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Survival Analysis	1994
Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. American journal of clinical oncology, 1993, Volume: 16, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Ethinyl Estradiol; Female; Fever; Fluorouracil; Hematologic Diseases; Humans; Infections; Length of Stay; Lymphatic Metastasis; Mastectomy, Modified Radical; Middle Aged; Neoplasm Staging; Pilot Projects; Remission Induction	1993
A phase I-II study of epirubicin, 5-fluorouracil, and leucovorin in advanced adenocarcinoma of the stomach. Cancer, 1993, Apr-01, Volume: 71, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Stomach Neoplasms	1993
Comparison of single-agent epirubicin and 5-fluorouracil/epirubicin/mitomycin in patients with advanced adenocarcinoma of the pancreas. Oncology, 1993, Volume: 50 Suppl 1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Neoplasm Staging; Pancreatic Neoplasms	1993
Weekly chemotherapy in advanced prostatic cancer. British journal of cancer, 1993, Volume: 67, Issue:6 Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Bone Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Humans; Male; Middle Aged; Osteoblasts; Prostatic Neoplasms	1993
Phase II study of high dose epirubicin in combination with cyclophosphamide in patients with advanced breast cancer. Australian and New Zealand journal of medicine, 1995, Volume: 25, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Epirubicin; Female; Humans; Middle Aged	1995
Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study. British journal of cancer, 1996, Volume: 73, Issue:4 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Epirubicin; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Leucovorin; Lymphatic Metastasis; Neoplasm Staging; Proportional Hazards Models; Recurrence; Stomach Neoplasms; Survival Rate; Time Factors	1996
Phase I/II trial of dexverapamil, epirubicin, and granulocyte-macrophage-colony stimulating factor in patients with advanced pancreatic adenocarcinoma. Cancer, 1995, Oct-15, Volume: 76, Issue:8 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Pancreatic Neoplasms; Treatment Outcome; Verapamil	1995
A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer. British journal of cancer, 1996, Volume: 73, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Pancreatic Neoplasms	1996
Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival. Cancer, 1996, May-15, Volume: 77, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Quality of Life; Stomach Neoplasms; Survival Analysis	1996
Phase I/II trial of dexverapamil, epirubicin and granulocyte/macrophage-colony-stimulating factor in patients with advanced pancreatic adenocarcinoma. Journal of cancer research and clinical oncology, 1995, Volume: 121 Suppl 3 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcium Channel Blockers; Drug Resistance, Multiple; Epirubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Pancreatic Neoplasms; Verapamil	1995
Intermittent continuous infusion of 5-fluorouracil in combination with epirubicin and cisplatin in advanced gastric cancer: the importance of dose intensity. The Journal of infusional chemotherapy, 1996,Spring, Volume: 6, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intravenous; Male; Middle Aged; Stomach Neoplasms	1996
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:12 Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine	1996
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Costs and Cost Analysis; Doxorubicin; Drug Costs; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Quality of Life; Stomach Neoplasms; Survival Rate	1997
Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma. Gynecologic oncology, 1997, Volume: 64, Issue:3 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Female; Follow-Up Studies; Humans; Hysterectomy; Neoplasm Staging; Survival Rate; Uterine Cervical Neoplasms; Vaginal Neoplasms	1997
Suramin/epidoxorubicin association in hormone-refractory prostate cancer: preliminary results of a pilot phase II study. Journal of cancer research and clinical oncology, 1997, Volume: 123, Issue:7 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Humans; Male; Pilot Projects; Prostatic Neoplasms; Suramin	1997
A phase II study of continuous infusion 5-fluorouracil (5-FU) with epirubicin and cisplatin in metastatic, hormone-resistant prostate cancer: an active new regimen. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:8 Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Epirubicin; Fluorouracil; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Treatment Outcome	1997
Treatment of advanced pancreatic cancer with epirubicin, 5-fluorouracil and 1-leucovorin: a phase II study. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Palliative Care; Pancreatic Neoplasms	1997
Phase II study of weekly 4'-epidoxorubicin in patients with metastatic adenocarcinoma of the cervix: an EORTC Gynaecological Cancer Cooperative Group study. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Humans; Middle Aged; Survival Rate; Uterine Cervical Neoplasms	1997
Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Endometrial Neoplasms; Epirubicin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Uterine Cervical Neoplasms	1997
Mobilization, collection, and characterization of peripheral blood hemopoietic progenitors after chemotherapy with epirubicin, paclitaxel, and granulocyte-colony stimulating factor administered to patients with metastatic breast carcinoma. Cancer, 1998, Mar-01, Volume: 82, Issue:5 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunophenotyping; Infusions, Intravenous; Middle Aged; Paclitaxel	1998
Seventy-two hour epirubicin infusion plus quinidine in unresectable and metastatic adenocarcinoma of the pancreas: a phase II trial. American journal of clinical oncology, 1998, Volume: 21, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Immunohistochemistry; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Quinidine; Survival Analysis; Tumor Suppressor Protein p53	1998
Advanced carcinoma of the pancreas: phase II study of combined chemotherapy, beta-interferon, and retinoids. American journal of clinical oncology, 1998, Volume: 21, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Diterpenes; Epirubicin; Female; Fluorouracil; Humans; Interferon-beta; Leucovorin; Male; Middle Aged; Mitomycin; Pancreatic Neoplasms; Retinyl Esters; Survival Rate; Vitamin A	1998
[Influence of preoperative on gastric cancer tissues and cells]. Zhonghua wai ke za zhi [Chinese journal of surgery], 1997, Volume: 35, Issue:5 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Preoperative Care; Stomach Neoplasms	1997
Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy. Bone marrow transplantation, 1999, Volume: 24, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Epirubicin; Erythropoietin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Prospective Studies; Recombinant Proteins; Transplantation Conditioning; Transplantation, Autologous	1999
Epirubicin, cisplatin, oral UFT, and calcium folinate in advanced gastric carcinoma. Oncology (Williston Park, N.Y.), 1999, Volume: 13, Issue:7 Suppl 3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Drug Administration Routes; Epirubicin; Female; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Retrospective Studies; Stomach Neoplasms; Tegafur; Treatment Outcome; Uracil	1999
Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma. British journal of cancer, 1999, Volume: 80, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; Deoxycytidine; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Patient Selection; Survival Rate; Time Factors	1999
Successful initial treatment with weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin chemotherapy in advanced gastric cancer patients with disseminated intravascular coagulation. Japanese journal of clinical oncology, 2000, Volume: 30, Issue:3 Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disseminated Intravascular Coagulation; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Stomach Neoplasms; Survival Rate	2000
A dose-finding study of raltitrexed (tomudex) with cisplatin and epirubicin in advanced gastro-oesophageal adenocarcinoma. British journal of cancer, 2000, Volume: 82, Issue:12 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Epirubicin; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Quinazolines; Stomach Neoplasms; Thiophenes; Treatment Outcome	2000
Intra-arterial chemotherapy for unresectable pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:5 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Catheters, Indwelling; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Male; Middle Aged; Pain; Pancreatic Neoplasms; Survival Analysis; Treatment Outcome	2000
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy. Lung cancer (Amsterdam, Netherlands), 2000, Volume: 29, Issue:2 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Salvage Therapy; Survival Analysis; Taiwan; Tamoxifen; Treatment Outcome	2000
CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma. Gynecologic oncology, 2001, Volume: 80, Issue:1 Topics: Adenocarcinoma; Adult; Aged; alpha Catenin; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Biomarkers, Tumor; Bleomycin; Cadherins; Carcinoma, Adenosquamous; Cisplatin; Cytoskeletal Proteins; Disease-Free Survival; Epirubicin; Etoposide; Female; Glycoproteins; Humans; Hyaluronan Receptors; Hysterectomy; Immunohistochemistry; Middle Aged; Neoadjuvant Therapy; Survival Rate; Trans-Activators; Uterine Cervical Neoplasms	2001
Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up. British journal of cancer, 2001, Apr-06, Volume: 84, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Multivariate Analysis; Stomach Neoplasms	2001
Adjuvant chemotherapy for gastro-oesophageal cancer with epirubicin, cisplatin and fluorouracil: a single-centre experience. Clinical oncology (Royal College of Radiologists (Great Britain)), 2001, Volume: 13, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Analysis; Treatment Outcome	2001
Definitive results of a phase II trial of cisplatin, epirubicin, continuous-infusion fluorouracil, and gemcitabine in stage IV pancreatic adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, May-15, Volume: 19, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Treatment Outcome	2001
Phase II study of epirubicin, mitomycin C, and 5-fluorouracil in hormone-refractory prostatic carcinoma. American journal of clinical oncology, 2001, Volume: 24, Issue:3 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Epirubicin; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate	2001
A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Drug Hypersensitivity; Enteritis; Epirubicin; Esophageal Neoplasms; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Pulmonary Embolism; Quinazolines; Sepsis; Stomach Neoplasms; Survival Analysis; Thiophenes; Treatment Outcome	2001
A phase II study of epirubicin in patients with advanced adenocarcinoma of the pancreas. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:8-9 Topics: Adenocarcinoma; Aged; Drug Evaluation; Epirubicin; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms	1992
Association of epirubicin, etoposide and cisplatin in gastric cancer. A phase II study. Oncology, 1991, Volume: 48, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Humans; Middle Aged; Stomach Neoplasms	1991
Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre. Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:5 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Protocols; Epirubicin; Female; Humans; Lymph Node Excision; Mastectomy; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Thiotepa; Vincristine; Vindesine	1991
A phase III randomized trial of epirubicin versus 5-fluorouracil in metastatic rectal/sigmoid adenocarcinoma. American journal of clinical oncology, 1989, Volume: 12, Issue:4 Topics: Adenocarcinoma; Clinical Trials as Topic; Epirubicin; Fluorouracil; Humans; Neoplasm Metastasis; Random Allocation; Rectal Neoplasms; Sigmoid Neoplasms; Time Factors	1989
A randomized study comparing platinum, doxorubicin, and VP-16 with platinum, 4'-epidoxorubicin, and VP-16 in patients with non-small-cell lung cancer. American journal of clinical oncology, 1987, Volume: 10, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Podophyllotoxin; Random Allocation	1987

Other Studies

189 other study(ies) available for epirubicin and Adenocarcinoma, Basal Cell

Article	Year
Effect of perioperative FLOT versus ECF/ECX on short-term outcomes after surgery for resectable oesophagogastric adenocarcinoma: propensity score-matched study. BJS open, 2022, 01-06, Volume: 6, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Cohort Studies; Docetaxel; Epirubicin; Esophageal Neoplasms; Fluorouracil; Humans; Leucovorin; Oxaliplatin; Perioperative Care; Propensity Score; Stomach Neoplasms; Treatment Outcome	2022
Real-world outcomes of cisplatin, capecitabine, and gemcitabine with either epirubicin (PEXG) or docetaxel (PDXG) as first-line palliative treatment in metastatic or unresectable locally advanced pancreatic adenocarcinoma. Asia-Pacific journal of clinical oncology, 2023, Volume: 19, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Docetaxel; Epirubicin; Febrile Neutropenia; Gemcitabine; Humans; Middle Aged; Palliative Care; Pancreatic Neoplasms; Retrospective Studies; Stomach Neoplasms; Treatment Outcome	2023
Clinical management patterns of advanced and metastatic gastro-oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United Kingdom. European journal of cancer care, 2020, Volume: 29, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Ambulatory Care; Analgesics, Opioid; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Disease Progression; Docetaxel; Emergency Service, Hospital; Epirubicin; Esophagogastric Junction; Female; Fluorouracil; France; Germany; Guideline Adherence; Hospice Care; Hospitalization; Humans; Irinotecan; Male; Middle Aged; Nutritional Support; Oxaliplatin; Palliative Care; Practice Guidelines as Topic; Practice Patterns, Physicians'; Receptor, ErbB-2; Retrospective Studies; Spain; Stomach Neoplasms; Treatment Failure; United Kingdom	2020
Perioperative chemotherapy for gastric cancer in FLOT4. Lancet (London, England), 2020, 01-11, Volume: 395, Issue:10218 Topics: Adenocarcinoma; Capecitabine; Cisplatin; Docetaxel; Epirubicin; Fluorouracil; Humans; Leucovorin; Oxaliplatin; Stomach Neoplasms	2020
Perioperative chemotherapy for gastric cancer in FLOT4. Lancet (London, England), 2020, 01-11, Volume: 395, Issue:10218 Topics: Adenocarcinoma; Capecitabine; Cisplatin; Docetaxel; Epirubicin; Fluorouracil; Humans; Leucovorin; Oxaliplatin; Stomach Neoplasms	2020
Outcomes and survival following neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus: Inverse propensity score weighted analysis. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2020, Volume: 46, Issue:12 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Disease-Free Survival; Docetaxel; Epirubicin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Esophagogastric Junction; Female; Fluorouracil; Hospital Mortality; Humans; Length of Stay; Leucovorin; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oxaliplatin; Postoperative Complications; Propensity Score; Survival Rate; Treatment Outcome	2020
Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma: A Multi-institutional Analysis. Annals of surgery, 2021, 10-01, Volume: 274, Issue:4 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Chemoradiotherapy; Cohort Studies; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Propensity Score; Stomach Neoplasms; Survival Rate; Treatment Outcome	2021
Union is strength: Textbook outcome with perioperative chemotherapy compliance decreases the risk of death in advanced gastric cancer patients. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2022, Volume: 48, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Docetaxel; Epirubicin; Female; Fluorouracil; Gastrectomy; Guideline Adherence; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Outcome and Process Assessment, Health Care; Oxaliplatin; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Stomach Neoplasms; Survival Rate	2022
Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma. Annals of surgical oncology, 2017, Volume: 24, Issue:8 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carboplatin; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Perioperative Care; Preoperative Care; Prognosis; Prospective Studies; Retrospective Studies; Stomach Neoplasms; Survival Rate	2017
[Multimodal therapy for gastric or gastroesophageal junction adenocarcinoma -ECF vs. FLOT]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2017, Volume: 88, Issue:6 Topics: Adenocarcinoma; Capecitabine; Cisplatin; Docetaxel; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Fluorouracil; Humans; Leucovorin; Neoadjuvant Therapy; Oxaliplatin	2017
Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma. The British journal of surgery, 2017, Volume: 104, Issue:13 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Stomach Neoplasms	2017
Metastasis in the mandibular condyle: a case report. Journal of medical case reports, 2017, Nov-16, Volume: 11, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Fatal Outcome; Female; Fluorouracil; Humans; Magnetic Resonance Imaging; Mandibular Condyle; Mandibular Neoplasms; Middle Aged; Positron-Emission Tomography; Radiography, Panoramic; Temporomandibular Joint Disorders; Tomography, X-Ray Computed	2017
Reversal of Multidrug Resistance in an Epirubicin-Resistant Gastric Cancer Cell Subline Asian Pacific journal of cancer prevention : APJCP, 2018, May-26, Volume: 19, Issue:5 Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Humans; RNA, Small Interfering; Stomach Neoplasms; Tumor Cells, Cultured	2018
Perioperative ECX chemotherapy in older adults with gastroesophageal adenocarcinoma. Journal of geriatric oncology, 2018, Volume: 9, Issue:6 Topics: Adenocarcinoma; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Epirubicin; Esophageal Neoplasms; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Retrospective Studies; Treatment Outcome	2018
Transcriptional upregulation of c-MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma. Molecular oncology, 2018, Volume: 12, Issue:12 Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Apoptosis; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Cell Line, Tumor; Drug Resistance, Neoplasm; Epirubicin; Esophageal Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myc; Receptor Protein-Tyrosine Kinases; Transcriptional Activation; Triazoles	2018
An Organoid-Based Preclinical Model of Human Gastric Cancer. Cellular and molecular gastroenterology and hepatology, 2019, Volume: 7, Issue:1 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Proliferation; Epirubicin; Epithelium; Fluorouracil; Gene Ontology; Humans; Inhibitory Concentration 50; Mice; Organoids; Oxaliplatin; Phenotype; Receptor, ErbB-2; Reproducibility of Results; Sequence Analysis, RNA; Stomach Neoplasms; Xenograft Model Antitumor Assays	2019
The Role of Continuing Perioperative Chemotherapy Post Surgery in Patients with Esophageal or Gastroesophageal Junction Adenocarcinoma: a Multicenter Cohort Study. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2019, Volume: 23, Issue:9 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Humans; Male; Margins of Excision; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm, Residual; Perioperative Period; Propensity Score; Retrospective Studies; Survival Rate	2019
Perioperative EOX treatment in operable locally advanced gastroesophageal adenocarcinoma: Prediction of tumor response by FDG -PET and histopathology. Surgical oncology, 2019, Volume: 28 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Oxaliplatin; Perioperative Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate; Young Adult	2019
Perioperative FLOT: new standard for gastric cancer? Lancet (London, England), 2019, 05-11, Volume: 393, Issue:10184 Topics: Adenocarcinoma; Capecitabine; Cisplatin; Docetaxel; Epirubicin; Fluorouracil; Humans; Leucovorin; Oxaliplatin; Stomach Neoplasms	2019
Perioperative FLOT superior to ECF/X. Nature reviews. Clinical oncology, 2019, Volume: 16, Issue:8 Topics: Adenocarcinoma; Capecitabine; Cisplatin; Docetaxel; Epirubicin; Fluorouracil; Humans; Leucovorin; Oxaliplatin	2019
Epirubicin loaded to pre-polymerized poly(butyl cyanoacrylate) nanoparticles: preparation and in vitro evaluation in human lung adenocarcinoma cells. Colloids and surfaces. B, Biointerfaces, 2013, Jul-01, Volume: 107 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Cell Line, Tumor; Chemistry, Pharmaceutical; Colloids; Drug Screening Assays, Antitumor; Enbucrilate; Endocytosis; Epirubicin; Humans; Light; Lung Neoplasms; Microscopy, Fluorescence; Nanoparticles; Particle Size; Polymerization; Scattering, Radiation; Static Electricity	2013
Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinoma. Anticancer research, 2013, Volume: 33, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Epirubicin; Esophagogastric Junction; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Stomach Neoplasms	2013
Impact of adjuvant chemotherapy cycles on prognosis of resectable stomach cancer: a retrospective analysis. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Gastrectomy; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Proportional Hazards Models; Retrospective Studies; Stomach Neoplasms	2013
Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2013, Volume: 67, Issue:4 Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Apoptosis; Area Under Curve; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Half-Life; Liposomes; Male; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Oligonucleotides, Antisense; Polyethylene Glycols; Rats; Rats, Sprague-Dawley	2013
Venous thromboembolism in patients receiving perioperative chemotherapy for esophagogastric cancer. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2014, Volume: 27, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Catheterization, Peripheral; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorouracil; Humans; Length of Stay; Male; Middle Aged; Neoadjuvant Therapy; Perioperative Period; Pulmonary Embolism; Retrospective Studies; Stomach Neoplasms; Survival Rate; Venous Thromboembolism; Venous Thrombosis; Young Adult	2014
Comparison between DCF (Docetaxel, Cisplatin and 5-Fluorouracil) and modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for adenocarcinoma of the upper gastrointestinal tract. Anticancer research, 2013, Volume: 33, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Docetaxel; Epirubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Retrospective Studies; Taxoids; Treatment Outcome; Upper Gastrointestinal Tract	2013
Retrospective analysis of docetaxel, oxaliplatin plus fluorouracil compared with epirubicin, cisplatin and fluorouracil as first-line therapy for advanced gastric cancer. Journal of chemotherapy (Florence, Italy), 2014, Volume: 26, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Stomach Neoplasms; Taxoids	2014
The postoperative component of MAGIC chemotherapy is associated with improved prognosis following surgical resection in gastric and gastrooesophageal junction adenocarcinomas. International journal of surgical oncology, 2013, Volume: 2013 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Risk Factors; Stomach Neoplasms	2013
The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction. Journal of surgical oncology, 2014, Volume: 109, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anastomotic Leak; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Databases, Factual; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorouracil; Gastrectomy; Hospitals, University; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Predictive Value of Tests; Prognosis; Prospective Studies; Stomach Neoplasms; United Kingdom	2014
Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus. World journal of gastroenterology, 2013, Dec-28, Volume: 19, Issue:48 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Endosonography; England; Epirubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Hospital Mortality; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2013
Impact of neoadjuvant chemotherapy with PELF-protocoll versus surgery alone in the treatment of advanced gastric carcinoma. BMC surgery, 2014, Jan-24, Volume: 14 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Analysis; Treatment Outcome	2014
Neoadjuvant chemotherapy followed by robotic radical hysterectomy in locally advanced cervical cancer: a multi-institution study. Gynecologic oncology, 2014, Volume: 133, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Epirubicin; Feasibility Studies; Female; Humans; Hysterectomy; Ifosfamide; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Pelvis; Retrospective Studies; Robotics; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult	2014
Retrospective analysis of adjuvant chemotherapy for curatively resected gastric cancer. World journal of gastroenterology, 2014, Mar-28, Volume: 20, Issue:12 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; China; Cisplatin; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Retrospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome	2014
Molecular profiling in gastric cancer: examining potential targets for chemotherapy. Journal of surgical oncology, 2014, Volume: 110, Issue:3 Topics: Adenocarcinoma; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers; Cisplatin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Endonucleases; Epirubicin; Female; Fluorouracil; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Proteins; Poly-ADP-Ribose Binding Proteins; Stomach Neoplasms; Thymidylate Synthase	2014
Outcomes in gastric and junctional cancer using neoadjuvant and adjuvant chemotherapy (epirubicin, oxaliplatin, and capecitabine) and radical surgery. Irish journal of medical science, 2015, Volume: 184, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Epirubicin; Esophagogastric Junction; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Stomach Neoplasms; Survival Rate; Treatment Outcome	2015
A nationwide retrospective study of perioperative chemotherapy for gastroesophageal adenocarcinoma: tolerability, outcome, and prognostic factors. Annals of surgical oncology, 2015, Volume: 22, Issue:5 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Perioperative Care; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate	2015
Management of Dysphagia in Esophageal Adenocarcinoma Patients Undergoing Neoadjuvant Chemotherapy: Can Invasive Tube Feeding be Avoided? Annals of surgical oncology, 2015, Volume: 22, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deglutition Disorders; Docetaxel; Enteral Nutrition; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Prospective Studies; Quality of Life; Taxoids	2015
Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:3 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Composition; Capecitabine; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Prognosis; Sarcopenia; Stomach Neoplasms; Tomography, X-Ray Computed	2015
Safety, efficacy, and long-term follow-up evaluation of perioperative epirubicin, Cisplatin, and capecitabine chemotherapy in esophageal resection for adenocarcinoma. Annals of surgical oncology, 2015, Volume: 22, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Perioperative Care; Prognosis; Retrospective Studies; Safety; Stomach Neoplasms; Survival Rate; Time Factors	2015
High Impact of Histopathological Remission for Prognosis after Perioperative Chemotherapy with ECF and ECF-Like Regimens for Gastric and Gastroesophageal Adenocarcinoma. Oncology, 2015, Volume: 89, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Perioperative Period; Retrospective Studies; Stomach Neoplasms; Survival Analysis; Treatment Outcome	2015
Perioperative chemotherapy in gastroesophageal cancer. A retrospective monocenter evaluation of 42 cases. PloS one, 2015, Volume: 10, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Diarrhea; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Organoplatinum Compounds; Oxaliplatin; Perioperative Care; Retrospective Studies; Stomach; Stomach Neoplasms; Survival Analysis	2015
Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma. Annals of surgical oncology, 2015, Volume: 22 Suppl 3 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Postoperative Complications; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids	2015
Prognostic impact of preoperative platelets to lymphocytes ratio (PLR) on survival for oesophageal and junctional carcinoma treated with neoadjuvant chemotherapy: A retrospective monocentric study on 153 patients. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Cohort Studies; Disease-Free Survival; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorouracil; Humans; Lymphocyte Count; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Platelet Count; Preoperative Period; Prognosis; Retrospective Studies; ROC Curve; Survival Rate	2015
Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:10 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Databases, Factual; Docetaxel; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorouracil; Gastrectomy; Humans; Kaplan-Meier Estimate; Leucovorin; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Postoperative Period; Prospective Studies; Retrospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome	2015
The impact of neoadjuvant chemotherapy on cardiopulmonary physical fitness in gastro-oesophageal adenocarcinoma. Annals of the Royal College of Surgeons of England, 2016, Volume: 98, Issue:6 Topics: Adenocarcinoma; Aged; Anaerobic Threshold; Antineoplastic Combined Chemotherapy Protocols; Cardiorespiratory Fitness; Cisplatin; Epirubicin; Esophageal Neoplasms; Exercise Test; Fluorouracil; Humans; Neoadjuvant Therapy; Oxygen Consumption; Postoperative Complications; Retrospective Studies; Stomach Neoplasms	2016
Full robot-assisted gastrectomy: surgical technique and preliminary experience from a single center. Journal of robotic surgery, 2016, Volume: 10, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anastomosis, Roux-en-Y; Antineoplastic Combined Chemotherapy Protocols; Blood Loss, Surgical; Blood Transfusion; Capecitabine; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Gastrectomy; Humans; Infusions, Intravenous; Learning Curve; Male; Middle Aged; Operative Time; Organoplatinum Compounds; Oxaliplatin; Perioperative Care; Prospective Studies; Robotic Surgical Procedures; Stomach Neoplasms; Young Adult	2016
Feasibility of robotic radical hysterectomy after neoadjuvant chemotherapy in women with locally advanced cervical cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2016, Volume: 42, Issue:9 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Feasibility Studies; Female; Humans; Hysterectomy; Ifosfamide; Longitudinal Studies; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Retrospective Studies; Robotic Surgical Procedures; Taxoids; Uterine Cervical Neoplasms	2016
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017, Volume: 20, Issue:3 Topics: Adenocarcinoma; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Disease-Free Survival; DNA Topoisomerases, Type II; DNA-Binding Proteins; Epirubicin; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Poly-ADP-Ribose Binding Proteins; Prognosis; Receptor, ErbB-2; Stomach Neoplasms; Treatment Outcome	2017
Surgical treatment of solitary sternal metastasis from breast cancer Case report. Annali italiani di chirurgia, 2016, May-25, Volume: 87 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Epirubicin; Female; Fractures, Spontaneous; Humans; Middle Aged; Myocutaneous Flap; Pleura; Sternum	2016
Efficacy of preoperative chemotherapy regimens in patients with initially unresectable locally advanced gastric adenocarcinoma: capecitabine and oxaliplatin (XELOX) or with epirubicin (EOX). Oncotarget, 2016, 11-15, Volume: 7, Issue:46 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Combined Modality Therapy; Deoxycytidine; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Oxaloacetates; Preoperative Care; Prospective Studies; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Young Adult	2016
It Is Time to Stop Using Epirubicin to Treat Any Patient With Gastroesophageal Adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Volume: 35, Issue:4 Topics: Adenocarcinoma; Cetuximab; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Humans; Stomach Neoplasms	2017
The role of adjuvant platinum-based chemotherapy in esophagogastric cancer patients who received neoadjuvant chemotherapy prior to definitive surgery. Journal of surgical oncology, 2017, Volume: 115, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Stomach Neoplasms; United Kingdom	2017
Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survival. Journal of surgical oncology, 2017, Volume: 115, Issue:7 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carboplatin; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Disease Progression; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Follow-Up Studies; Humans; Leukopenia; Male; Middle Aged; Neoadjuvant Therapy; Netherlands; Paclitaxel; Propensity Score; Thromboembolism	2017
Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer. Gynecologic oncology, 2008, Volume: 111, Issue:3 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Conization; Epirubicin; Female; Humans; Hysterectomy; Ifosfamide; Lymph Node Excision; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Uterine Cervical Neoplasms; Young Adult	2008
[Analysis of the diagnosis and treatment of cervical minimal deviation adenocarcinoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:10 Topics: Actins; Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Cervix Uteri; Chemotherapy, Adjuvant; Cisplatin; Conization; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Papanicolaou Test; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms; Vaginal Smears	2008
Encephalopathy secondary to capecitabine chemotherapy: a case report and discussion. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2009, Volume: 15, Issue:4 Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Neurotoxicity Syndromes	2009
[Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues]. Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cisplatin; Colonic Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epirubicin; Female; Fluorouracil; Genes, MDR; Humans; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organoplatinum Compounds; Oxaliplatin; Rectal Neoplasms; RNA, Messenger	2009
Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy. Histopathology, 2009, Volume: 55, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Combined Modality Therapy; Deoxycytidine; Dose-Response Relationship, Drug; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Platinum; Remission Induction; Retrospective Studies; Single-Blind Method; Stomach Neoplasms; Treatment Outcome	2009
Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era. International journal of radiation oncology, biology, physics, 2010, Jul-15, Volume: 77, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carboplatin; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Mastectomy, Modified Radical; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Radiodermatitis; Radiotherapy, Adjuvant; Retrospective Studies	2010
[A case in which intra-arterial chemotherapy for simultaneous hepatic metastases markedly improved AFP-producing gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12 Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorouracil; Gastrectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Stomach Neoplasms	2009
[Complete response to M-FAP chemotherapy for multiple lung metastases after segmental resection of urachal carcinoma : a case report]. Hinyokika kiyo. Acta urologica Japonica, 2010, Volume: 56, Issue:2 Topics: Adenocarcinoma; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Fluorouracil; Humans; Lung Neoplasms; Male; Methotrexate; Urachus; Urinary Bladder Neoplasms	2010
The cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG) regimen in advanced biliary tract adenocarcinoma. Cancer, 2010, May-01, Volume: 116, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Deoxycytidine; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Infusions, Intra-Arterial; Male; Middle Aged	2010
Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy. British journal of cancer, 2010, Jul-13, Volume: 103, Issue:2 Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Line, Tumor; Cisplatin; Drug Screening Assays, Antitumor; Epirubicin; Esophageal Neoplasms; Fluorouracil; Humans; Mice; Mice, SCID; Protein Array Analysis; Proteomics; Sensitivity and Specificity; Treatment Outcome	2010
Prognostic significance of age in the radical treatment of oesophageal cancer with surgery or chemoradiotherapy: a prospective observational cohort study. Clinical oncology (Royal College of Radiologists (Great Britain)), 2010, Volume: 22, Issue:7 Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Radiotherapy Dosage; Survival Rate; Treatment Outcome	2010
Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy. Radiology, 2010, Volume: 257, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Contrast Media; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; In Situ Hybridization, Fluorescence; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Neoplasm, Residual; Prospective Studies; ROC Curve; Statistics, Nonparametric; Taxoids	2010
Synergistic gastric cancer inhibition by chemogenetherapy with recombinant human adenovirus p53 and epirubicin: an in vitro and in vivo study. Oncology reports, 2010, Volume: 24, Issue:6 Topics: Adenocarcinoma; Adenoviridae; Algorithms; Animals; Antineoplastic Agents; Cell Line, Tumor; Combined Modality Therapy; Drug Synergism; Epirubicin; Female; Genetic Therapy; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Recombinant Proteins; Stomach Neoplasms; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2010
Outcomes from chemoradiotherapy for patients with esophageal cancer. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2011, Volume: 24, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Survival Rate; Treatment Outcome	2011
Rechallenge with platinum plus fluoropyrimidine +/- epirubicin in patients with oesophagogastric cancer. Oncology, 2010, Volume: 79, Issue:1-2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Esophageal Neoplasms; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Palliative Care; Platinum Compounds; Pyrimidines; Retrospective Studies; Stomach Neoplasms; Treatment Outcome	2010
Esophageal adenocarcinoma after laparoscopic gastric band placement for obesity. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2011, Volume: 24, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bariatric Surgery; Deglutition Disorders; Disease Progression; Epirubicin; Esophageal Neoplasms; Fatal Outcome; Fluorouracil; Gastroesophageal Reflux; Humans; Male; Obesity; Organoplatinum Compounds; Oxaliplatin	2011
Defining cure for esophageal cancer: analysis of actual 5-year survivors following esophagectomy. Annals of surgical oncology, 2011, Volume: 18, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Survival Rate; Survivors; Treatment Outcome	2011
Esophageal adenocarcinoma presenting as pseudo-achalasia in a patient with juvenile polyposis syndrome: an enemy out of the blue. Digestive diseases and sciences, 2011, Volume: 56, Issue:7 Topics: Adenocarcinoma; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiemetics; Antineoplastic Agents; Antineoplastic Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Epirubicin; Esophageal Achalasia; Esophageal Neoplasms; Fatal Outcome; Fluorouracil; Humans; Intestinal Polyposis; Liver Neoplasms; Male; Neoplastic Syndromes, Hereditary; Peritoneal Neoplasms; Proton Pump Inhibitors; Taxoids; Trastuzumab	2011
Expressions of topoisomerase IIα and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients. Pathology oncology research : POR, 2011, Volume: 17, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; DNA Topoisomerases, Type II; DNA-Binding Proteins; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Prospective Studies; Real-Time Polymerase Chain Reaction; RNA, Messenger; Small Cell Lung Carcinoma; Survival Rate; Treatment Outcome; Vault Ribonucleoprotein Particles; Vincristine	2011
[Evaluation of the efficacy of bronchial arterial infusion chemotherapy for the treatment of central non-small cell lung cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Survival Rate	2011
Safety and efficacy of self-expanding removable metal esophageal stents during neoadjuvant chemotherapy for resectable esophageal cancer. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2012, Volume: 25, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Weight; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Deglutition Disorders; Epirubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Malnutrition; Middle Aged; Neoadjuvant Therapy; Prosthesis Failure; Serum Albumin; Severity of Illness Index; Stents	2012
Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial. BMC cancer, 2011, Jun-24, Volume: 11 Topics: Adenocarcinoma; Antineoplastic Agents; Capecitabine; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Docetaxel; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Germany; Humans; Multicenter Studies as Topic; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Salvage Therapy; Taxoids; Treatment Outcome	2011
Risk of thromboembolic events after perioperative chemotherapy versus surgery alone for esophageal adenocarcinoma. Annals of surgical oncology, 2012, Volume: 19, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Perioperative Care; Prognosis; Prospective Studies; Risk Factors; Thromboembolism	2012
Nonsurgical management of esophageal adenocarcinoma. Clinical colorectal cancer, 2011, Volume: 10, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Cohort Studies; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Induction Chemotherapy; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Survival Rate; Treatment Outcome	2011
Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediate. Cancer biotherapy & radiopharmaceuticals, 2012, Volume: 27, Issue:1 Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Epirubicin; Female; Humans; Immunoglobulin G; Photochemical Processes; Receptor, ErbB-2; Tumor Cells, Cultured; Ultraviolet Rays	2012
Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT. Acta oncologica (Stockholm, Sweden), 2012, Volume: 51, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Taxoids; Tomography, X-Ray Computed	2012
Bilateral acute ptosis leading to the diagnosis of a presumed metastatic gastric adenocarcinoma. Orbit (Amsterdam, Netherlands), 2012, Volume: 31, Issue:2 Topics: Acute Disease; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Blepharoptosis; Capecitabine; Deoxycytidine; Epirubicin; Fatal Outcome; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Orbital Neoplasms; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed	2012
Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma. The British journal of surgery, 2012, Volume: 99, Issue:8 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Deoxycytidine; Epirubicin; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pancreatic Neoplasms; Postoperative Complications; Treatment Outcome	2012
Effects of neo-adjuvant chemotherapy for oesophago-gastric cancer on neuro-muscular gastric function. Molecular biology reports, 2012, Volume: 39, Issue:12 Topics: Acetylcholinesterase; Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carbachol; Chemotherapy, Adjuvant; Cholinergic Agonists; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Ganglia, Autonomic; Gastric Emptying; Gastric Mucosa; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Neoadjuvant Therapy; Stomach; Stomach Neoplasms	2012
The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic agents. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2012, Volume: 33, Issue:6 Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Proliferation; Epirubicin; Humans; Kallikreins; Methotrexate; Organoplatinum Compounds; Oxaliplatin; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms; Tumor Cells, Cultured; Up-Regulation	2012
pH-and thermo-sensitive pluronic/poly(acrylic acid) in situ hydrogels for sustained release of an anticancer drug. Journal of drug targeting, 2013, Volume: 21, Issue:1 Topics: Acrylic Resins; Adenocarcinoma; Administration, Oral; Animals; Antibiotics, Antineoplastic; Area Under Curve; Biological Availability; Colonic Neoplasms; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Epirubicin; Half-Life; Hydrogels; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Scanning; Poloxamer; Rats; Rats, Sprague-Dawley; Temperature	2013
Surgical outcomes of robotic radical hysterectomy after neoadjuvant chemotherapy for locally advanced cervical cancer: comparison with early stage disease. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2013, Volume: 39, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Dose Fractionation, Radiation; Epirubicin; Feasibility Studies; Female; Humans; Hysterectomy; Ifosfamide; Laparoscopy; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiotherapy, Adjuvant; Robotics; Safety; Treatment Outcome; Uterine Cervical Neoplasms; Vagina	2013
A potential daidzein derivative enhances cytotoxicity of epirubicin on human colon adenocarcinoma Caco-2 cells. International journal of molecular sciences, 2012, Dec-21, Volume: 14, Issue:1 Topics: Adenocarcinoma; Caco-2 Cells; Caspases; Cell Death; Cell Proliferation; Colonic Neoplasms; DNA Fragmentation; Drug Synergism; Epirubicin; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Intracellular Space; Isoflavones; Membrane Potential, Mitochondrial; Models, Biological; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; RNA, Messenger	2012
Sensitivity of gastric adenocarcinoma and normal cell lines against combined or conjugated antimetabolites. Anti-cancer drugs, 2013, Volume: 24, Issue:4 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cell Line, Tumor; Chromatography, High Pressure Liquid; Cisplatin; Cytidine; Cytostatic Agents; Deoxyuridine; Drug Resistance, Neoplasm; Drug Synergism; Epirubicin; Fibroblasts; Humans; Molecular Structure; Oligonucleotides; Prodrugs; Skin; Stomach; Stomach Neoplasms; Tumor Stem Cell Assay	2013
Postoperative chemoradiotherapy combined with epirubicin-based triplet chemotherapy for locally advanced adenocarcinoma of the stomach or gastroesophageal junction. PloS one, 2013, Volume: 8, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Esophagogastric Junction; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Postoperative Period; Retrospective Studies; Stomach	2013
Adjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junction. Radiation oncology (London, England), 2013, Feb-11, Volume: 8 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organs at Risk; Prognosis; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate	2013
Fixed erythrodysaesthesia plaque due to gemcitabine and epirubicin treatment. Acta dermato-venereologica, 2002, Volume: 82, Issue:2 Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Drug Eruptions; Epirubicin; Erythema; Gemcitabine; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Paresthesia; Skin; Taxoids	2002
Epirubicin, Cisplatin, and protracted venous-infusion Fluorouracil in advanced esophagogastric cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Oct-01, Volume: 20, Issue:19 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials, Phase III as Topic; Epirubicin; Esophageal Neoplasms; Fluorouracil; Humans; Infusions, Intravenous; Mitomycins; Quality of Life; Stomach Neoplasms	2002
[Clinical efficacy of the combination chemotherapy of high-dose epirubicin in non-small cell lung cancer]. Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 2001, Aug-28, Volume: 26, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin	2001
Effect of different neoadjuvant chemotherapy regimens on locally advanced breast cancer. Neoplasma, 2003, Volume: 50, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Survival Rate	2003
Adenocarcinoma of the salivary gland? A chemo-sensitive disease. Clinical oncology (Royal College of Radiologists (Great Britain)), 2004, Volume: 16, Issue:2 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Fluorouracil; Humans; Leeching; Lymphedema; Male; Middle Aged; Palliative Care; Radiotherapy, Adjuvant; Salivary Gland Neoplasms	2004
A rare life-threatening complication of migrated nitinol self-expanding metallic stent (Ultraflex). Surgical endoscopy, 2004, Volume: 18, Issue:2 Topics: Adenocarcinoma; Aged; Alloys; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deglutition Disorders; Device Removal; Epirubicin; Equipment Design; Esophageal Neoplasms; Fluorouracil; Foreign-Body Migration; Humans; Ileal Diseases; Intestinal Obstruction; Laparotomy; Liver Neoplasms; Male; Postoperative Complications; Stents	2004
A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix. International journal of clinical oncology, 2004, Volume: 9, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Radiotherapy, Adjuvant; Statistics as Topic; Treatment Outcome; Uterine Cervical Neoplasms; Women's Health	2004
ECF in gastric cancer. Clinical oncology (Royal College of Radiologists (Great Britain)), 2004, Volume: 16, Issue:5 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Fluorouracil; Humans; Middle Aged; Prognosis; Stomach Neoplasms; Treatment Outcome; United Kingdom	2004
Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancer. British journal of cancer, 2004, Oct-18, Volume: 91, Issue:8 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Epirubicin; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; Soft Tissue Neoplasms; Survival Rate	2004
Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors. Cancer, 2005, Apr-01, Volume: 103, Issue:7 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cholangiocarcinoma; Cisplatin; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neutropenia; Survival Rate; Venous Thrombosis	2005
[Experimental studies of anti-proliferative effects of marinesponge extracts S1 - S3 on human lung adenocarcinoma and hepatocarcinoma cells]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2005, Volume: 28, Issue:3 Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Epirubicin; Humans; Liver Neoplasms; Lung Neoplasms; Materia Medica; Porifera; Stomach Neoplasms	2005
Increased dosage of epirubicin and mitomycin-C for the treatment of metastatic adenocarcinoma of unknown primary site. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Biopsy; Dose-Response Relationship, Drug; Epirubicin; Humans; Leukopenia; Male; Mitomycin; Neoplasm Metastasis; Neoplasms, Unknown Primary; Neutropenia; Treatment Outcome	1989
[A case of breast cancer detected by MRI mammography after Hollywood syndrome]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:11 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Implants; Breast Neoplasms; Carcinoma, Papillary; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Magnetic Resonance Imaging; Middle Aged; Sentinel Lymph Node Biopsy	2005
[A case of postoperative liver metastasis from bile duct carcinoma responding to transarterial chemoembolization]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Chemoembolization, Therapeutic; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Mitomycin; Polymers; Postoperative Period; Remission Induction	2006
Neoadjuvant chemotherapy for locally advanced carcinoma of the lower oesophagus and oesophago-gastric junction. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2006, Volume: 32, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Stomach Neoplasms; Survival Rate	2006
Conformal radiotherapy in the adjuvant treatment of gastric cancer: Review of 82 cases. International journal of radiation oncology, biology, physics, 2006, Jul-01, Volume: 65, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Retrospective Studies; Stomach Neoplasms; Survival Analysis	2006
Capecitabine, epirubicin and cisplatin in the treatment of oesophagogastric adenocarcinoma. The Netherlands journal of medicine, 2006, Volume: 64, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Retrospective Studies; Stomach Neoplasms; Survival Analysis	2006
Response to neoadjuvant chemotherapy in breast cancer could be predictable by measuring a novel serum apoptosis product, caspase-cleaved cytokeratin 18: a prospective pilot study. Cancer investigation, 2006, Volume: 24, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Immunoenzyme Techniques; Keratin-18; Middle Aged; Neoadjuvant Therapy; Pilot Projects; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Taxoids; Treatment Outcome	2006
[Prolonged hypoxia induces GST-pi expression and drug resistance in lung adenocarcinoma cell line SPCA1]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2007, Volume: 30, Issue:2 Topics: Adenocarcinoma; Cell Hypoxia; Cell Line, Tumor; Drug Resistance, Neoplasm; Epirubicin; Glutathione S-Transferase pi; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mitomycin; Plasmids; Transfection	2007
The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice. Annals of surgical oncology, 2007, Volume: 14, Issue:10 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Feasibility Studies; Fluorouracil; Gastrectomy; Humans; Infusions, Intravenous; Multicenter Studies as Topic; Neoadjuvant Therapy; Randomized Controlled Trials as Topic; Research Design; Stomach Neoplasms; United Kingdom	2007
Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Annals of surgical oncology, 2007, Volume: 14, Issue:10 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Fluorouracil; Gastrectomy; Humans; Lymph Node Excision; Multicenter Studies as Topic; Neoadjuvant Therapy; Neoplasm Staging; Randomized Controlled Trials as Topic; Research Design; Stomach Neoplasms; United Kingdom	2007
Epirubicin, cisplatin, oral UFT, and leucovorin combination chemotherapy in advanced and metastatic esophageal cancer. Medical oncology (Northwood, London, England), 2007, Volume: 24, Issue:1 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Esophageal Neoplasms; Female; Humans; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Prognosis; Survival Rate; Tegafur; Treatment Outcome; Uracil	2007
Metastatic esophageal adenocarcinoma presenting in the iris. American journal of ophthalmology, 2007, Volume: 144, Issue:3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Fluorouracil; Humans; Iris Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin	2007
[18F]2-fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil. British journal of cancer, 2007, Oct-08, Volume: 97, Issue:7 Topics: Adenocarcinoma; Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Flow Cytometry; Fluorodeoxyglucose F18; Fluorouracil; Humans; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Tumor Cells, Cultured	2007
Oncolytic adenovirus Ad5/3-delta24 and chemotherapy for treatment of orthotopic ovarian cancer. Gynecologic oncology, 2008, Volume: 108, Issue:1 Topics: Adenocarcinoma; Adenoviridae; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Epirubicin; Female; Gemcitabine; Humans; Mice; Mice, SCID; Oncolytic Virotherapy; Ovarian Neoplasms; Virus Replication; Xenograft Model Antitumor Assays	2008
Histological features of breast cancer, highly sensitive to chemotherapy. Breast cancer (Tokyo, Japan), 2007, Volume: 14, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Epirubicin; Female; Humans; Middle Aged; Neoadjuvant Therapy; Paclitaxel	2007
Prognostic factors in patients treated with taxane-based chemotherapy for recurrent or metastatic endometrial cancer: proposal for a new prognostic model. Gynecologic oncology, 2008, Volume: 108, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Endometrial Neoplasms; Epirubicin; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Topotecan	2008
Metastatic ductal eccrine adenocarcinoma masquerading as an invasive ductal carcinoma of the male breast. Journal of cutaneous pathology, 2007, Volume: 34, Issue:12 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Cyclophosphamide; Diphosphonates; Eccrine Glands; Epirubicin; Fluorouracil; Humans; Ibandronic Acid; Immunohistochemistry; Lung Neoplasms; Lymphatic Metastasis; Male; Radiotherapy; Sweat Gland Neoplasms; Tamoxifen; Tomography, X-Ray Computed	2007
[Reversal effect and mechanism of arsenic trioxide on multidrug resistance of gastric carcinoma cells SGC7901]. Yao xue xue bao = Acta pharmaceutica Sinica, 2007, Volume: 42, Issue:9 Topics: Adenocarcinoma; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Fluorouracil; Glutathione Transferase; Humans; Oxides; Stomach Neoplasms; Vincristine	2007
Solamargine enhances HER2 expression and increases the susceptibility of human lung cancer H661 and H69 cells to trastuzumab and epirubicin. Chemical research in toxicology, 2008, Volume: 21, Issue:2 Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Combinations; Drug Screening Assays, Antitumor; Drug Synergism; Epirubicin; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Lung Neoplasms; Poly-ADP-Ribose Binding Proteins; Solanaceous Alkaloids; Trastuzumab; Up-Regulation	2008
Determining the morphological features of breast cancer and predicting the effects of neoadjuvant chemotherapy via diagnostic breast imaging. Breast cancer (Tokyo, Japan), 2008, Volume: 15, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cyclophosphamide; Diagnostic Imaging; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Prognosis; Retrospective Studies; Stereoisomerism; Treatment Outcome	2008
Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung. European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:4 Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Doxorubicin; Drug Evaluation; Epirubicin; Humans; Lung Neoplasms; Time Factors	1984
Phase II trial of 4'epi-adriamycin for advanced hypernephroma. American journal of clinical oncology, 1983, Volume: 6, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Kidney Neoplasms; Leukopenia; Male; Middle Aged; Thrombocytopenia	1983
4'-epi-doxorubicin in combination with cisplatin in advanced ovarian cancer. Cancer treatment reports, 1984, Volume: 68, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cystadenocarcinoma; Doxorubicin; Epirubicin; Female; Humans; Middle Aged; Ovarian Neoplasms	1984
Curative treatments of murine Colon26 solid tumors by immunochemotherapy with G-CSF and OK-432. Immunopharmacology, 1995, Volume: 29, Issue:3 Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Cytotoxicity, Immunologic; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Immunologic Factors; Macrophages; Mice; Mice, Inbred BALB C; Mitomycin; Neoplasm Proteins; Picibanil; Recombinant Proteins; Tumor Cells, Cultured	1995
[Intra-arterial infusion chemotherapy for advanced liver metastases from lung cancer via implantable vascular access: report of six cases]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:11 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin	1995
[A case of liver metastasis of gastric cancer with portal vein tumor thrombosis responding to chemotherapy with 5-FU and epirubicin]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:9 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fluorouracil; Humans; Liver Neoplasms; Male; Parenteral Nutrition, Total; Portal Vein; Stomach Neoplasms; Thrombosis	1995
[Effectiveness of transthoracic puncture in the diagnosis and treatment of neoplasms of chest organs]. Voprosy onkologii, 1994, Volume: 40, Issue:1-3 Topics: Adenocarcinoma; Adolescent; Aged; Biopsy, Needle; Carcinoma, Squamous Cell; Doxorubicin; Epirubicin; Evaluation Studies as Topic; Female; Humans; Lung; Lung Neoplasms; Male; Mediastinal Neoplasms; Mediastinum; Middle Aged; Pneumonectomy; Radiography	1994
[Etoposide, epirubicin and cisplatin (EEP) combination in metastatic cancers of the cardia and the stomach. Groupe de recherche en cancérologie du Nord (GRECNO)]. Bulletin du cancer, 1994, Volume: 81, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cardia; Cisplatin; Epirubicin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Treatment Outcome	1994
[Home therapy approach in cancer patients-chemotherapy (case 2-3)--intra-arterial infusion cancer chemotherapy for hepatic metastasis of colorectal cancer--case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21 Suppl 4 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Cisplatin; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Home Infusion Therapy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin	1994
FLEP (5-fluorouracil, leucovorin, etoposide, cisplatin) in advanced gastric cancer. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Stomach Neoplasms	1994
[Chemotherapy in the treatment of brain metastases of breast cancers]. Bulletin du cancer, 1994, Volume: 81, Issue:3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Fluorouracil	1994
[A case of metastatic breast cancer successfully treated with weekly low-dose epirubicin (EPI), cyclophosphamide (CPA), 5-fluorouracil (5-FU) and medroxyprogesterone (MPA)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:14 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Medroxyprogesterone; Middle Aged; Tamoxifen	1994
Epirubicin plus a calmodulin inhibitor (trifluoperazine) activity in advanced pancreatic adenocarcinoma. T.T.D. Cooperative Spanish Group. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:7 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Multiple; Epirubicin; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Trifluoperazine	1994
[A case of advanced gastric cancer successfully treated with resection after FEP (5-FU, epirubicin, CDDP) combined chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:15 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Epirubicin; Fluorouracil; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Male; Middle Aged; Neoplasm Invasiveness; Stomach Neoplasms	1994
[Hypervascular liver metastases of gastric cancer completely responding to transcatheter oily chemoembolization using epirubicin hydrochloride, mitomycin C and lipiodol]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:10 Topics: Adenocarcinoma; Aged; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Iodized Oil; Liver Neoplasms; Mitomycin; Stomach Neoplasms	1994
[Advanced breast cancer with onset of multi-organ metastases successfully treated with combined loco-regional therapies: a case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:11 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cholestasis; Combined Modality Therapy; Drainage; Epirubicin; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mastectomy; Middle Aged; Mitomycin; Pleural Effusion, Malignant	1993
Natural killer cell activity and progression-free survival in ovarian cancer. Gynecologic and obstetric investigation, 1993, Volume: 35, Issue:2 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cystadenoma; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Endometriosis; Epirubicin; Female; Follow-Up Studies; Humans; Killer Cells, Natural; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis	1993
Clinical effects on CA 15-3 level of cyclosporin A as a chemosensitiser in chemoresistant metastatic breast cancer. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:3 Topics: Adenocarcinoma; Antigens, Tumor-Associated, Carbohydrate; Bone Neoplasms; Breast Neoplasms; Cyclosporine; Drug Resistance; Epirubicin; Female; Humans; Middle Aged	1993
[Superselective bronchial arterial infusion therapy with cisplatin and epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hilar lung adenocarcinoma: preliminary clinical experience]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1993, Sep-25, Volume: 53, Issue:9 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Cisplatin; Epirubicin; Humans; Infusions, Intra-Arterial; Iodized Oil; Iohexol; Lung Neoplasms; Male; Mitomycins	1993
Intra- and perivesical tumor growth in preoperative staging of bladder cancer: the role of transrectal ultrasonography and high resolution magnetic resonance imaging. Urologia internationalis, 1993, Volume: 50, Issue:3 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Staging; Preoperative Care; Rectum; Sensitivity and Specificity; Ultrasonography; Urinary Bladder Neoplasms; Vinblastine	1993
Endometrioid carcinoma of the ovary. Retrospective study. European journal of gynaecological oncology, 1993, Volume: 14, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Endometriosis; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Retrospective Studies; Survival Rate; Tamoxifen	1993
Epirubicin, etoposide and cisplatin in advanced pancreatic carcinoma. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:8 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Humans; Male; Middle Aged; Pancreatic Neoplasms	1993
Modulation of multidrug resistance with dexniguldipine hydrochloride (B8509-035) in the CC531 rat colon carcinoma model. Journal of cancer research and clinical oncology, 1996, Volume: 122, Issue:7 Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Colonic Neoplasms; Dihydropyridines; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Drug Synergism; Epirubicin; Male; Neoplasm Transplantation; Rats; Rats, Inbred Strains; Tumor Cells, Cultured	1996
The importance of continued endocrine treatment during chemotherapy of hormone-refractory prostate cancer. European urology, 1997, Volume: 31, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diethylstilbestrol; Disease Progression; Epirubicin; Fluorouracil; Goserelin; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms	1997
[A case of hepatic arterial infusion chemotherapy for multiple liver metastasis from breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:12 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mastectomy; Middle Aged; Pleural Neoplasms	1997
Inflammatory breast cancer: enhanced local control with hyperfractionated radiotherapy and infusional vincristine, ifosfamide and epirubicin. Australian and New Zealand journal of medicine, 1998, Volume: 28, Issue:3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Dose Fractionation, Radiation; Drug Administration Schedule; Epirubicin; Female; Humans; Ifosfamide; Infusion Pumps; Mesna; Neoplasm Staging; Survival Rate; Treatment Outcome; Vincristine	1998
[Intra-arterial infusion chemotherapy for advanced endometrial cancer before surgical treatment]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Endometrial Neoplasms; Epirubicin; Female; Humans; Hysterectomy; Infusions, Intra-Arterial; Lymph Node Excision; Middle Aged; Mitomycin; Preoperative Care	1998
[Neoadjuvant intraarterial chemotherapy for ten cases of inflammatory breast cancer by Seldinger's methods]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Catheters, Indwelling; Chemotherapy, Adjuvant; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Middle Aged	1998
[Probable choroid metastasis of an esophageal adenocarcinoma that regressed with chemotherapy]. Gastroenterologie clinique et biologique, 1998, Volume: 22, Issue:3 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Choroid Neoplasms; Cisplatin; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Visual Acuity	1998
[A case of advanced gallbladder cancer responding to neoadjuvant intra-arterial chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Duodenum; Epirubicin; Female; Fluorouracil; Gallbladder Neoplasms; Hepatectomy; Humans; Infusions, Intra-Arterial; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Pancreatectomy; Tegafur; Uracil	1999
[Neoadjuvant chemotherapy FEC-HD in locally advanced breast cancer]. Bulletin du cancer, 1999, Volume: 86, Issue:2 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Thrombocytopenia	1999
Prognosis of primary fallopian tube adenocarcinoma: report of 25 patients. European journal of gynaecological oncology, 1998, Volume: 19, Issue:6 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Fallopian Tube Neoplasms; Fallopian Tubes; Female; Follow-Up Studies; Humans; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Registries; Retrospective Studies; Risk Factors	1998
[Intraarterial chemotherapy for uterine cervical adenocarcinoma: evaluation of its efficacy as neoadjuvant therapy]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1999, Volume: 59, Issue:12 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Magnetic Resonance Imaging; Middle Aged; Mitomycin; Neoadjuvant Therapy; Treatment Outcome; Uterine Cervical Neoplasms	1999
Current trends in the surgical treatment of esophageal and cardia adenocarcinoma. Journal of experimental & clinical cancer research : CR, 1999, Volume: 18, Issue:3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Cardia; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Diagnostic Imaging; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Fluorouracil; Gastroesophageal Reflux; Humans; Italy; Leucovorin; Life Tables; Lymph Node Excision; Lymphatic Metastasis; Mediastinum; Neoadjuvant Therapy; Neoplasm Staging; Palliative Care; Postoperative Complications; Retrospective Studies; Stomach Neoplasms; Survival Analysis	1999
[A case of recurrent pancreatic cancer brought into a complete response by a multimodal treatment with intraarterial chemotherapy and radiotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Mitomycin; Pancreatic Neoplasms; Remission Induction	2000
[A clinical report of high-dose epirubicin combined with cyclophosphamide and fluorouracil for advanced breast cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 1998, Volume: 20, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Medullary; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging	1998
Preoperative ECF chemotherapy in gastro-oesophageal adenocarcinoma. Clinical oncology (Royal College of Radiologists (Great Britain)), 2000, Volume: 12, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Stomach Neoplasms; Survival Rate	2000
[Long-term survival of a patient with postoperative liver metastasis of stage IVa gallbladder cancer responding to hepatic arterial infusion chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:3 Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Duodenal Neoplasms; Epirubicin; Fluorouracil; Gallbladder Neoplasms; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin	2001
Chemotherapy response of breast cancer depends on HER-2 status and anthracycline dose intensity in the neoadjuvant setting. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:6 Topics: Adenocarcinoma; Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Immunohistochemistry; Middle Aged; Multivariate Analysis; Receptor, ErbB-2; Treatment Outcome	2001
Resistance to topoisomerase poisons due to loss of DNA mismatch repair. International journal of cancer, 2001, Aug-15, Volume: 93, Issue:4 Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Base Pair Mismatch; Breast Neoplasms; Carrier Proteins; Colorectal Neoplasms; Deoxycytidine; DNA Repair; DNA-Binding Proteins; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Enzyme Inhibitors; Epirubicin; Female; Gemcitabine; Humans; Intercalating Agents; Mitoxantrone; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Paclitaxel; Proto-Oncogene Proteins; Taxoids; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors	2001
Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary site. Medical oncology (Northwood, London, England), 2001, Volume: 18, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Carcinoma; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms, Unknown Primary; Patient Selection; Retrospective Studies; Survival Analysis; Treatment Outcome	2001
In vitro models of a three-drug regimen (epirubicin, cisplatin and fluorouracil) for the treatment of colorectal cancer. Chemotherapy, 2001, Volume: 47, Issue:6 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cisplatin; Colonic Neoplasms; Drug Interactions; Drug Resistance, Neoplasm; Epirubicin; Fluorescent Dyes; Fluorouracil; Humans; Rhodamines; Tumor Cells, Cultured	2001
Relationship between Fas/FasL expression and apoptosis of colon adenocarcinoma cell lines. World journal of gastroenterology, 2001, Volume: 7, Issue:1 Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Cisplatin; Colonic Neoplasms; Epirubicin; Fas Ligand Protein; fas Receptor; Flow Cytometry; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Membrane Glycoproteins; Mitomycins; Tumor Cells, Cultured	2001
Uterine carcinoma in a 10-month-old golden retriever. The Journal of small animal practice, 2002, Volume: 43, Issue:3 Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Dog Diseases; Dogs; Epirubicin; Female; Uterine Neoplasms	2002
Chemotherapy as initial treatment for cervical carcinoma: clinical and tumor marker response. Acta obstetricia et gynecologica Scandinavica, 1992, Volume: 71, Issue:4 Topics: Adenocarcinoma; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Middle Aged; Serpins; Trypsin Inhibitor, Kazal Pancreatic; Uterine Cervical Neoplasms	1992
Influence of chemotherapy on hormone receptor concentration in a xenotransplanted endometrial cancer. European journal of obstetrics, gynecology, and reproductive biology, 1992, Jul-03, Volume: 45, Issue:2 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bleomycin; Carboplatin; Cyclophosphamide; Endometrial Neoplasms; Epirubicin; Female; Fluorouracil; Humans; Mice; Mice, Nude; Mitomycins; Neoplasm Transplantation; Receptors, Estradiol; Receptors, Progesterone; Transplantation, Heterologous	1992
[Successful treatment of adenocarcinoma of the lung with bone metastases by combined chemotherapy with epirubicin, mitomycin C and carboplatin]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:12 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Epirubicin; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin	1992
Primary chemotherapy for locally advanced uterine cervical carcinoma. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:8 Suppl Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Humans; Middle Aged; Nausea; Survival Rate; Uterine Cervical Neoplasms; Vomiting	1992
Selective regional chemotherapy of unresectable hepatic tumours using lipiodol. HPB surgery : a world journal of hepatic, pancreatic and biliary surgery, 1991, Volume: 4, Issue:3 Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Emulsions; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged	1991
5-Fluorouracil, epirubicin, and BCNU (FEB) in advanced measurable gastric cancer. American journal of clinical oncology, 1990, Volume: 13, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Palliative Care; Stomach Neoplasms; Survival Analysis	1990
Pancreatoblastoma: response to chemotherapy. Medical and pediatric oncology, 1991, Volume: 19, Issue:3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Vinblastine; Vincristine	1991
Epirubicin in advanced endometrial adenocarcinoma: a phase II study of the Grupo Ginecologico Español para el Tratamiento Oncologico (GGETO). European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Drug Evaluation; Endometrium; Epirubicin; Female; Humans; Middle Aged; Neoplasm Staging; Prognosis; Uterine Neoplasms; Vagina	1991
Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosph Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1991, Volume: 167, Issue:9 Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Biophysical Phenomena; Biophysics; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation, Preclinical; Electrons; Epirubicin; Female; Hydrogen-Ion Concentration; Ifosfamide; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Particle Accelerators	1991
[Hepatic arterial infusion of farmorubicin (FARM) and 5-fluorouracil (5-FU) in a patient with massive hepatic metastasis from gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:13 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Stomach Neoplasms	1991
Open phase II with 5-fluorouracil, 4-epi-doxorubicin and mitomycin C (FEM) in advanced gastric cancer. Tumori, 1990, Feb-28, Volume: 76, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evaluation; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms; Survival Rate	1990
Combination of 4-epi-doxorubicin and irradiation--a new approach in the treatment of locoregionally advanced inoperable esophageal cancer. Tumori, 1986, Feb-28, Volume: 72, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Doxorubicin; Epirubicin; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Palliative Care; Pilot Projects	1986
Cisplatin, epirubicin and 5-fluorouracil combination chemotherapy for recurrent carcinoma of the salivary gland. Tumori, 1989, Jun-30, Volume: 75, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Adenoid Cystic; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Salivary Gland Neoplasms	1989
An EORTC Gastrointestinal Group phase II evaluation of epirubicin combined with ifosfamide in advanced adenocarcinoma of the pancreas. EORTC Gastrointestinal Group. European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Epirubicin; Female; Humans; Ifosfamide; Male; Middle Aged; Pancreatic Neoplasms	1989
Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment. British journal of cancer, 1989, Volume: 60, Issue:5 Topics: 6-Ketoprostaglandin F1 alpha; Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cystadenocarcinoma; Endometriosis; Epirubicin; Female; Humans; Middle Aged; Ovarian Neoplasms; Thromboxane B2	1989
Epirubicin-induced primary Sjögren's syndrome. Lancet (London, England), 1986, Sep-13, Volume: 2, Issue:8507 Topics: Adenocarcinoma; Bone Neoplasms; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Middle Aged; Sjogren's Syndrome	1986
Effect of medroxyprogesterone acetate, alone or in combination with epirubicin hydrochloride, on the growth of the Dunning R3327H prostatic adenocarcinoma. European urology, 1987, Volume: 13, Issue:3 Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Doxorubicin; Epirubicin; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Transplantation; Orchiectomy; Prostatic Neoplasms; Rats; Testosterone	1987
[A phase II study of epirubicin in advanced lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:9 Topics: Adenocarcinoma; Aged; Anorexia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea	1986
[In vitro sensitivity testing of human kidney tumors to cytostatic drugs with a rapid in vitro test]. Urologia internationalis, 1986, Volume: 41, Issue:2 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cisplatin; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Humans; Kidney Neoplasms; Mitomycin; Mitomycins; Tumor Stem Cell Assay; Vincristine	1986
Phase II trial of 4'-epi-doxorubicin in locally advanced or metastatic gastric cancer. Tumori, 1988, Jun-30, Volume: 74, Issue:3 Topics: Adenocarcinoma; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Male; Middle Aged; Stereoisomerism; Stomach Neoplasms	1988
[Phase II study of epirubicin on gastric cancer--a cooperative study of the Tokai Cancer Chemotherapy Group]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Alopecia; Anemia; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Heart; Humans; Leukopenia; Male; Middle Aged; Stomach Neoplasms	1986
The 6 day subrenal capsule assay is of no value with primary surgical explants from gastric cancer. British journal of cancer, 1986, Volume: 54, Issue:3 Topics: Adenocarcinoma; Animals; Cisplatin; Doxorubicin; Drug Evaluation, Preclinical; Epirubicin; Fluorouracil; Humans; Kidney; Methotrexate; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Stomach Neoplasms	1986
An EORTC Gastrointestinal Group phase II evaluation of epirubicin combined with 5-fluorouracil in advanced adenocarcinoma of the pancreas. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:7 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evaluation; Epirubicin; Female; Fluorouracil; Humans; Male; Pancreatic Neoplasms	1987
Phase II study of epirubicin in advanced adenocarcinoma of the pancreas. European journal of cancer & clinical oncology, 1985, Volume: 21, Issue:2 Topics: Adenocarcinoma; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms	1985
Phase II trial of epirubicin in gastric cancer. Cancer treatment reports, 1985, Volume: 69, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Anemia; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Stroke Volume	1985